PMCID	SUBJECT_SCOPE_ID	S_START	S_END	SUBJECT_SCOPE	CONCEPT	IGNORANCE TYPE	C_START	C_END	CONCEPT_MENTION_ID
PMC1168874	PMC1168874_0	[0]	[95]	['Risk and Benefit of Drug Use During Pregnancy\n\nAbstract\nEnvironmental teratogenic factors (e.g.']	Drug	CHEBI_EXT	[20]	[24]	PMC1168874_T0
PMC1168874	PMC1168874_0	[0]	[95]	['Risk and Benefit of Drug Use During Pregnancy\n\nAbstract\nEnvironmental teratogenic factors (e.g.']	Pregnancy	GO_BP_EXT	[36]	[45]	PMC1168874_T235
PMC1168874	PMC1168874_0	[0]	[95]	['Risk and Benefit of Drug Use During Pregnancy\n\nAbstract\nEnvironmental teratogenic factors (e.g.']	teratogenic	CHEBI_EXT	[70]	[81]	PMC1168874_T1
PMC1168874	PMC1168874_1	[96]	[121]	['alcohol) are preventable.']	alcohol	CHEBI_EXT	[96]	[103]	PMC1168874_T2
PMC1168874	PMC1168874_2	[122]	[218]	['We focus our analysis on human teratogenic drugs which are not used frequently during pregnancy.']	human	NCBITAXON_EXT	[147]	[152]	PMC1168874_T376
PMC1168874	PMC1168874_2	[122]	[218]	['We focus our analysis on human teratogenic drugs which are not used frequently during pregnancy.']	teratogenic	CHEBI_EXT	[153]	[164]	PMC1168874_T3
PMC1168874	PMC1168874_2	[122]	[218]	['We focus our analysis on human teratogenic drugs which are not used frequently during pregnancy.']	teratogenic	GO_BP_EXT	[153]	[164]	PMC1168874_T236
PMC1168874	PMC1168874_2	[122]	[218]	['We focus our analysis on human teratogenic drugs which are not used frequently during pregnancy.']	drugs	CHEBI_EXT	[165]	[170]	PMC1168874_T4
PMC1168874	PMC1168874_2	[122]	[218]	['We focus our analysis on human teratogenic drugs which are not used frequently during pregnancy.']	pregnancy	GO_BP_EXT	[208]	[217]	PMC1168874_T237
PMC1168874	PMC1168874_3	[219]	[299]	['The previous human teratogenic studies had serious methodological problems, e.g.']	human	NCBITAXON_EXT	[232]	[237]	PMC1168874_T377
PMC1168874	PMC1168874_4	[300]	[444]	['the first trimester concept is outdated because environmental teratogens cannot induce congenital abnormalities in the first month of gestation.']	teratogens	CHEBI_EXT	[362]	[372]	PMC1168874_T5
PMC1168874	PMC1168874_4	[300]	[444]	['the first trimester concept is outdated because environmental teratogens cannot induce congenital abnormalities in the first month of gestation.']	gestation	GO_BP_EXT	[434]	[443]	PMC1168874_T238
PMC1168874	PMC1168874_6	[531]	[686]	['Finally, the importance of chemical structures, administrative routes and reasons for treatment at the evaluation of medicinal products was not considered.']	chemical	CHEBI_EXT	[558]	[566]	PMC1168874_T6
PMC1168874	PMC1168874_6	[531]	[686]	['Finally, the importance of chemical structures, administrative routes and reasons for treatment at the evaluation of medicinal products was not considered.']	medicinal	CHEBI_EXT	[648]	[657]	PMC1168874_T7
PMC1168874	PMC1168874_8	[800]	[941]	['These biases explain that the teratogenic risk of drugs is exaggerated, while the benefit of medicine use during pregnancy is underestimated.']	teratogenic	GO_BP_EXT	[830]	[841]	PMC1168874_T239
PMC1168874	PMC1168874_8	[800]	[941]	['These biases explain that the teratogenic risk of drugs is exaggerated, while the benefit of medicine use during pregnancy is underestimated.']	drugs	CHEBI_EXT	[850]	[855]	PMC1168874_T8
PMC1168874	PMC1168874_8	[800]	[941]	['These biases explain that the teratogenic risk of drugs is exaggerated, while the benefit of medicine use during pregnancy is underestimated.']	medicine	CHEBI_EXT	[893]	[901]	PMC1168874_T9
PMC1168874	PMC1168874_8	[800]	[941]	['These biases explain that the teratogenic risk of drugs is exaggerated, while the benefit of medicine use during pregnancy is underestimated.']	pregnancy	GO_BP_EXT	[913]	[922]	PMC1168874_T240
PMC1168874	PMC1168874_9	[942]	[1040]	['Thus, a better balance is needed between the risk and benefit of drug treatments during pregnancy.']	drug	CHEBI_EXT	[1007]	[1011]	PMC1168874_T10
PMC1168874	PMC1168874_9	[942]	[1040]	['Thus, a better balance is needed between the risk and benefit of drug treatments during pregnancy.']	pregnancy	GO_BP_EXT	[1030]	[1039]	PMC1168874_T241
PMC1168874	PMC1168874_10	[1041]	[1225]	['Of course, we have to do our best to reduce the risk of teratogenic drugs as much as possible, however, it is worth stressing the preventive effect of drugs for maternal diseases (e.g.']	teratogenic	CHEBI_EXT	[1097]	[1108]	PMC1168874_T11
PMC1168874	PMC1168874_10	[1041]	[1225]	['Of course, we have to do our best to reduce the risk of teratogenic drugs as much as possible, however, it is worth stressing the preventive effect of drugs for maternal diseases (e.g.']	drugs	CHEBI_EXT	[1109]	[1114]	PMC1168874_T12
PMC1168874	PMC1168874_10	[1041]	[1225]	['Of course, we have to do our best to reduce the risk of teratogenic drugs as much as possible, however, it is worth stressing the preventive effect of drugs for maternal diseases (e.g.']	drugs	CHEBI_EXT	[1192]	[1197]	PMC1168874_T13
PMC1168874	PMC1168874_13	[1300]	[1495]	['Introduction\nAmong environmental factors, dangerous lifestyle seems to be the greatest hazard for the development of the fetus due to the common practice of consuming alcohol and smoking tobacco.']	development of ... fetus	GO_BP_EXT	[1402, 1421]	[1416, 1426]	PMC1168874_T242
PMC1168874	PMC1168874_13	[1300]	[1495]	['Introduction\nAmong environmental factors, dangerous lifestyle seems to be the greatest hazard for the development of the fetus due to the common practice of consuming alcohol and smoking tobacco.']	consuming	GO_BP_EXT	[1457]	[1466]	PMC1168874_T243
PMC1168874	PMC1168874_13	[1300]	[1495]	['Introduction\nAmong environmental factors, dangerous lifestyle seems to be the greatest hazard for the development of the fetus due to the common practice of consuming alcohol and smoking tobacco.']	alcohol	CHEBI_EXT	[1467]	[1474]	PMC1168874_T14
PMC1168874	PMC1168874_14	[1496]	[1574]	['Alcohol may cause fetal alcohol syndrome or at least fetal alcohol effects1,2.']	Alcohol	CHEBI_EXT	[1496]	[1503]	PMC1168874_T15
PMC1168874	PMC1168874_14	[1496]	[1574]	['Alcohol may cause fetal alcohol syndrome or at least fetal alcohol effects1,2.']	alcohol	CHEBI_EXT	[1520]	[1527]	PMC1168874_T16
PMC1168874	PMC1168874_14	[1496]	[1574]	['Alcohol may cause fetal alcohol syndrome or at least fetal alcohol effects1,2.']	alcohol	CHEBI_EXT	[1555]	[1562]	PMC1168874_T17
PMC1168874	PMC1168874_15	[1575]	[1780]	['It is preventable by abstinence during pregnancy but often unavoidable because approximately 50% of pregnancies are unplanned and hence alcohol consumption occurs before a woman knows that she is pregnant.']	pregnancy	GO_BP_EXT	[1614]	[1623]	PMC1168874_T244
PMC1168874	PMC1168874_15	[1575]	[1780]	['It is preventable by abstinence during pregnancy but often unavoidable because approximately 50% of pregnancies are unplanned and hence alcohol consumption occurs before a woman knows that she is pregnant.']	pregnancies	GO_BP_EXT	[1675]	[1686]	PMC1168874_T245
PMC1168874	PMC1168874_15	[1575]	[1780]	['It is preventable by abstinence during pregnancy but often unavoidable because approximately 50% of pregnancies are unplanned and hence alcohol consumption occurs before a woman knows that she is pregnant.']	alcohol	CHEBI_EXT	[1711]	[1718]	PMC1168874_T18
PMC1168874	PMC1168874_15	[1575]	[1780]	['It is preventable by abstinence during pregnancy but often unavoidable because approximately 50% of pregnancies are unplanned and hence alcohol consumption occurs before a woman knows that she is pregnant.']	woman	NCBITAXON_EXT	[1747]	[1752]	PMC1168874_T378
PMC1168874	PMC1168874_15	[1575]	[1780]	['It is preventable by abstinence during pregnancy but often unavoidable because approximately 50% of pregnancies are unplanned and hence alcohol consumption occurs before a woman knows that she is pregnant.']	pregnant	GO_BP_EXT	[1771]	[1779]	PMC1168874_T246
PMC1168874	PMC1168874_16	[1781]	[2049]	['Recently the teratogenic potential of smoking has been shown in some congenital abnormalities (CAs), particularly terminal transverse type of limb deficiencies3and Poland sequence4, while the gene-environmental interaction was shown in the origin of orofacial clefts5.']	terminal	UBERON_EXT	[1895]	[1903]	PMC1168874_T443
PMC1168874	PMC1168874_16	[1781]	[2049]	['Recently the teratogenic potential of smoking has been shown in some congenital abnormalities (CAs), particularly terminal transverse type of limb deficiencies3and Poland sequence4, while the gene-environmental interaction was shown in the origin of orofacial clefts5.']	limb	UBERON_EXT	[1923]	[1927]	PMC1168874_T444
PMC1168874	PMC1168874_16	[1781]	[2049]	['Recently the teratogenic potential of smoking has been shown in some congenital abnormalities (CAs), particularly terminal transverse type of limb deficiencies3and Poland sequence4, while the gene-environmental interaction was shown in the origin of orofacial clefts5.']	sequence4	SO_EXT	[1952]	[1961]	PMC1168874_T432
PMC1168874	PMC1168874_16	[1781]	[2049]	['Recently the teratogenic potential of smoking has been shown in some congenital abnormalities (CAs), particularly terminal transverse type of limb deficiencies3and Poland sequence4, while the gene-environmental interaction was shown in the origin of orofacial clefts5.']	gene	SO_EXT	[1973]	[1977]	PMC1168874_T433
PMC1168874	PMC1168874_16	[1781]	[2049]	['Recently the teratogenic potential of smoking has been shown in some congenital abnormalities (CAs), particularly terminal transverse type of limb deficiencies3and Poland sequence4, while the gene-environmental interaction was shown in the origin of orofacial clefts5.']	orofacial	UBERON_EXT	[2031]	[2040]	PMC1168874_T445
PMC1168874	PMC1168874_17	[2050]	[2203]	['The role of teratogenic effect of environmental pollutants such as methyl mercury6was also reported but we cannot estimate the magnitude of this problem.']	teratogenic	CHEBI_EXT	[2062]	[2073]	PMC1168874_T19
PMC1168874	PMC1168874_17	[2050]	[2203]	['The role of teratogenic effect of environmental pollutants such as methyl mercury6was also reported but we cannot estimate the magnitude of this problem.']	pollutants	CHEBI_EXT	[2098]	[2108]	PMC1168874_T20
PMC1168874	PMC1168874_17	[2050]	[2203]	['The role of teratogenic effect of environmental pollutants such as methyl mercury6was also reported but we cannot estimate the magnitude of this problem.']	methyl mercury6was	CHEBI_EXT	[2117]	[2135]	PMC1168874_T21
PMC1168874	PMC1168874_18	[2204]	[2375]	['The primary prevention of infectious diseases by vaccination is extremely important particularly in the prevention of CA-syndromes caused by rubella and varicella viruses.']	rubella	NCBITAXON_EXT	[2345]	[2352]	PMC1168874_T379
PMC1168874	PMC1168874_18	[2204]	[2375]	['The primary prevention of infectious diseases by vaccination is extremely important particularly in the prevention of CA-syndromes caused by rubella and varicella viruses.']	varicella viruses	NCBITAXON_EXT	[2357]	[2374]	PMC1168874_T380
PMC1168874	PMC1168874_19	[2376]	[2437]	['Here we focus on teratogenic medication and their prevention.']	teratogenic	CHEBI_EXT	[2393]	[2404]	PMC1168874_T22
PMC1168874	PMC1168874_19	[2376]	[2437]	['Here we focus on teratogenic medication and their prevention.']	medication	CHEBI_EXT	[2405]	[2415]	PMC1168874_T23
PMC1168874	PMC1168874_21	[2442]	[2627]	['Human teratogenic drugs\nIn Hungary 92% of pregnant women used medicinal products and the mean number of drugs and pregnancy supplements per pregnant women was 3.4 between 1980 and 1996.']	Human	NCBITAXON_EXT	[2442]	[2447]	PMC1168874_T381
PMC1168874	PMC1168874_21	[2442]	[2627]	['Human teratogenic drugs\nIn Hungary 92% of pregnant women used medicinal products and the mean number of drugs and pregnancy supplements per pregnant women was 3.4 between 1980 and 1996.']	teratogenic	CHEBI_EXT	[2448]	[2459]	PMC1168874_T24
PMC1168874	PMC1168874_21	[2442]	[2627]	['Human teratogenic drugs\nIn Hungary 92% of pregnant women used medicinal products and the mean number of drugs and pregnancy supplements per pregnant women was 3.4 between 1980 and 1996.']	teratogenic	GO_BP_EXT	[2448]	[2459]	PMC1168874_T247
PMC1168874	PMC1168874_21	[2442]	[2627]	['Human teratogenic drugs\nIn Hungary 92% of pregnant women used medicinal products and the mean number of drugs and pregnancy supplements per pregnant women was 3.4 between 1980 and 1996.']	drugs	CHEBI_EXT	[2460]	[2465]	PMC1168874_T25
PMC1168874	PMC1168874_21	[2442]	[2627]	['Human teratogenic drugs\nIn Hungary 92% of pregnant women used medicinal products and the mean number of drugs and pregnancy supplements per pregnant women was 3.4 between 1980 and 1996.']	pregnant	GO_BP_EXT	[2484]	[2492]	PMC1168874_T248
PMC1168874	PMC1168874_21	[2442]	[2627]	['Human teratogenic drugs\nIn Hungary 92% of pregnant women used medicinal products and the mean number of drugs and pregnancy supplements per pregnant women was 3.4 between 1980 and 1996.']	women	NCBITAXON_EXT	[2493]	[2498]	PMC1168874_T382
PMC1168874	PMC1168874_21	[2442]	[2627]	['Human teratogenic drugs\nIn Hungary 92% of pregnant women used medicinal products and the mean number of drugs and pregnancy supplements per pregnant women was 3.4 between 1980 and 1996.']	medicinal	CHEBI_EXT	[2504]	[2513]	PMC1168874_T26
PMC1168874	PMC1168874_21	[2442]	[2627]	['Human teratogenic drugs\nIn Hungary 92% of pregnant women used medicinal products and the mean number of drugs and pregnancy supplements per pregnant women was 3.4 between 1980 and 1996.']	drugs	CHEBI_EXT	[2546]	[2551]	PMC1168874_T27
PMC1168874	PMC1168874_21	[2442]	[2627]	['Human teratogenic drugs\nIn Hungary 92% of pregnant women used medicinal products and the mean number of drugs and pregnancy supplements per pregnant women was 3.4 between 1980 and 1996.']	pregnancy	GO_BP_EXT	[2556]	[2565]	PMC1168874_T249
PMC1168874	PMC1168874_21	[2442]	[2627]	['Human teratogenic drugs\nIn Hungary 92% of pregnant women used medicinal products and the mean number of drugs and pregnancy supplements per pregnant women was 3.4 between 1980 and 1996.']	pregnant	GO_BP_EXT	[2582]	[2590]	PMC1168874_T250
PMC1168874	PMC1168874_21	[2442]	[2627]	['Human teratogenic drugs\nIn Hungary 92% of pregnant women used medicinal products and the mean number of drugs and pregnancy supplements per pregnant women was 3.4 between 1980 and 1996.']	women	NCBITAXON_EXT	[2591]	[2596]	PMC1168874_T383
PMC1168874	PMC1168874_22	[2628]	[2695]	['About 70% pregnant women were treated with drugs during pregnancy7.']	pregnant	GO_BP_EXT	[2638]	[2646]	PMC1168874_T251
PMC1168874	PMC1168874_22	[2628]	[2695]	['About 70% pregnant women were treated with drugs during pregnancy7.']	women	NCBITAXON_EXT	[2647]	[2652]	PMC1168874_T384
PMC1168874	PMC1168874_22	[2628]	[2695]	['About 70% pregnant women were treated with drugs during pregnancy7.']	drugs	CHEBI_EXT	[2671]	[2676]	PMC1168874_T28
PMC1168874	PMC1168874_22	[2628]	[2695]	['About 70% pregnant women were treated with drugs during pregnancy7.']	pregnancy7	GO_BP_EXT	[2684]	[2694]	PMC1168874_T252
PMC1168874	PMC1168874_24	[2755]	[2942]	['Experts in many countries have set up risk classification systems based on data from human and animal studies to help physicians interpret the risk associated with drugs during pregnancy.']	human	NCBITAXON_EXT	[2840]	[2845]	PMC1168874_T385
PMC1168874	PMC1168874_24	[2755]	[2942]	['Experts in many countries have set up risk classification systems based on data from human and animal studies to help physicians interpret the risk associated with drugs during pregnancy.']	animal	NCBITAXON_EXT	[2850]	[2856]	PMC1168874_T386
PMC1168874	PMC1168874_24	[2755]	[2942]	['Experts in many countries have set up risk classification systems based on data from human and animal studies to help physicians interpret the risk associated with drugs during pregnancy.']	drugs	CHEBI_EXT	[2919]	[2924]	PMC1168874_T29
PMC1168874	PMC1168874_24	[2755]	[2942]	['Experts in many countries have set up risk classification systems based on data from human and animal studies to help physicians interpret the risk associated with drugs during pregnancy.']	pregnancy	GO_BP_EXT	[2932]	[2941]	PMC1168874_T253
PMC1168874	PMC1168874_25	[2943]	[3103]	['The most well-known classification was introduced by the US Food and Drug Administration (FDA) in 1979, using the letters A, B, C, D and X for five categories9.']	Food ...	CHEBI_EXT	[3003]	[3007]	PMC1168874_T30
PMC1168874	PMC1168874_25	[2943]	[3103]	['The most well-known classification was introduced by the US Food and Drug Administration (FDA) in 1979, using the letters A, B, C, D and X for five categories9.']	Drug	CHEBI_EXT	[3012]	[3016]	PMC1168874_T31
PMC1168874	PMC1168874_27	[3188]	[3420]	['There is no appropriate data for drugs in category C. The definition of category D is as follows: “There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk” (e.g.']	drugs	CHEBI_EXT	[3221]	[3226]	PMC1168874_T32
PMC1168874	PMC1168874_27	[3188]	[3420]	['There is no appropriate data for drugs in category C. The definition of category D is as follows: “There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk” (e.g.']	human	NCBITAXON_EXT	[3317]	[3322]	PMC1168874_T387
PMC1168874	PMC1168874_27	[3188]	[3420]	['There is no appropriate data for drugs in category C. The definition of category D is as follows: “There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk” (e.g.']	pregnant	GO_BP_EXT	[3364]	[3372]	PMC1168874_T254
PMC1168874	PMC1168874_27	[3188]	[3420]	['There is no appropriate data for drugs in category C. The definition of category D is as follows: “There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk” (e.g.']	women	NCBITAXON_EXT	[3373]	[3378]	PMC1168874_T388
PMC1168874	PMC1168874_29	[3455]	[3550]	['Finally, drugs with classification X are “Contraindicated in women who are or may be pregnant”.']	drugs	CHEBI_EXT	[3464]	[3469]	PMC1168874_T33
PMC1168874	PMC1168874_29	[3455]	[3550]	['Finally, drugs with classification X are “Contraindicated in women who are or may be pregnant”.']	women	NCBITAXON_EXT	[3516]	[3521]	PMC1168874_T389
PMC1168874	PMC1168874_29	[3455]	[3550]	['Finally, drugs with classification X are “Contraindicated in women who are or may be pregnant”.']	pregnant	GO_BP_EXT	[3540]	[3548]	PMC1168874_T255
PMC1168874	PMC1168874_30	[3551]	[3754]	['We do not like this classification system, because all oral contraceptives and female sex hormones (both estrogens and progestins) were classified as X though we have no evidence of a teratogenic effect.']	oral	UBERON_EXT	[3606]	[3610]	PMC1168874_T446
PMC1168874	PMC1168874_30	[3551]	[3754]	['We do not like this classification system, because all oral contraceptives and female sex hormones (both estrogens and progestins) were classified as X though we have no evidence of a teratogenic effect.']	contraceptives	CHEBI_EXT	[3611]	[3625]	PMC1168874_T34
PMC1168874	PMC1168874_30	[3551]	[3754]	['We do not like this classification system, because all oral contraceptives and female sex hormones (both estrogens and progestins) were classified as X though we have no evidence of a teratogenic effect.']	female	UBERON_EXT	[3630]	[3636]	PMC1168874_T447
PMC1168874	PMC1168874_30	[3551]	[3754]	['We do not like this classification system, because all oral contraceptives and female sex hormones (both estrogens and progestins) were classified as X though we have no evidence of a teratogenic effect.']	sex hormones	CHEBI_EXT	[3637]	[3649]	PMC1168874_T35
PMC1168874	PMC1168874_30	[3551]	[3754]	['We do not like this classification system, because all oral contraceptives and female sex hormones (both estrogens and progestins) were classified as X though we have no evidence of a teratogenic effect.']	hormones	CHEBI_EXT	[3641]	[3649]	PMC1168874_T370
PMC1168874	PMC1168874_30	[3551]	[3754]	['We do not like this classification system, because all oral contraceptives and female sex hormones (both estrogens and progestins) were classified as X though we have no evidence of a teratogenic effect.']	estrogens	CHEBI_EXT	[3656]	[3665]	PMC1168874_T36
PMC1168874	PMC1168874_30	[3551]	[3754]	['We do not like this classification system, because all oral contraceptives and female sex hormones (both estrogens and progestins) were classified as X though we have no evidence of a teratogenic effect.']	progestins	CHEBI_EXT	[3670]	[3680]	PMC1168874_T37
PMC1168874	PMC1168874_31	[3755]	[3831]	['It is another matter that these hormones are not indicated during pregnancy.']	hormones	CHEBI_EXT	[3787]	[3795]	PMC1168874_T38
PMC1168874	PMC1168874_31	[3755]	[3831]	['It is another matter that these hormones are not indicated during pregnancy.']	hormones	CHEBI_EXT	[3787]	[3795]	PMC1168874_T371
PMC1168874	PMC1168874_31	[3755]	[3831]	['It is another matter that these hormones are not indicated during pregnancy.']	pregnancy	GO_BP_EXT	[3821]	[3830]	PMC1168874_T256
PMC1168874	PMC1168874_32	[3832]	[4011]	['We only found an association between very high doses of oestrogens and unimelic terminal transverse type of limb deficiency when oestrogens were used to induce illegal abortion10.']	oestrogens	CHEBI_EXT	[3888]	[3898]	PMC1168874_T39
PMC1168874	PMC1168874_32	[3832]	[4011]	['We only found an association between very high doses of oestrogens and unimelic terminal transverse type of limb deficiency when oestrogens were used to induce illegal abortion10.']	terminal	UBERON_EXT	[3912]	[3920]	PMC1168874_T448
PMC1168874	PMC1168874_32	[3832]	[4011]	['We only found an association between very high doses of oestrogens and unimelic terminal transverse type of limb deficiency when oestrogens were used to induce illegal abortion10.']	limb	UBERON_EXT	[3940]	[3944]	PMC1168874_T449
PMC1168874	PMC1168874_32	[3832]	[4011]	['We only found an association between very high doses of oestrogens and unimelic terminal transverse type of limb deficiency when oestrogens were used to induce illegal abortion10.']	oestrogens	CHEBI_EXT	[3961]	[3971]	PMC1168874_T40
PMC1168874	PMC1168874_33	[4012]	[4102]	['This general teratogenic risk for limb deficiency was about 1% instead of the usual 0.05%.']	limb	UBERON_EXT	[4046]	[4050]	PMC1168874_T450
PMC1168874	PMC1168874_35	[4226]	[4319]	['Finally some other drugs were classified as X without any evidence for teratogenic risk (e.g.']	drugs	CHEBI_EXT	[4245]	[4250]	PMC1168874_T41
PMC1168874	PMC1168874_36	[4320]	[4367]	['clomiphene) or with much debated findings (e.g.']	clomiphene	CHEBI_EXT	[4320]	[4330]	PMC1168874_T42
PMC1168874	PMC1168874_37	[4368]	[4438]	['benzodiazepine such as flurazepam, quazepam, temazepam and triazolam).']	benzodiazepine	CHEBI_EXT	[4368]	[4382]	PMC1168874_T43
PMC1168874	PMC1168874_37	[4368]	[4438]	['benzodiazepine such as flurazepam, quazepam, temazepam and triazolam).']	flurazepam	CHEBI_EXT	[4391]	[4401]	PMC1168874_T44
PMC1168874	PMC1168874_37	[4368]	[4438]	['benzodiazepine such as flurazepam, quazepam, temazepam and triazolam).']	temazepam	CHEBI_EXT	[4413]	[4422]	PMC1168874_T45
PMC1168874	PMC1168874_37	[4368]	[4438]	['benzodiazepine such as flurazepam, quazepam, temazepam and triazolam).']	triazolam	CHEBI_EXT	[4427]	[4436]	PMC1168874_T46
PMC1168874	PMC1168874_38	[4439]	[4637]	['This problem is more serious in the groups of drugs with classification D because many drugs were classified without any data and were based only on the general similarity of the chemical structure.']	drugs	CHEBI_EXT	[4485]	[4490]	PMC1168874_T47
PMC1168874	PMC1168874_38	[4439]	[4637]	['This problem is more serious in the groups of drugs with classification D because many drugs were classified without any data and were based only on the general similarity of the chemical structure.']	drugs	CHEBI_EXT	[4526]	[4531]	PMC1168874_T48
PMC1168874	PMC1168874_38	[4439]	[4637]	['This problem is more serious in the groups of drugs with classification D because many drugs were classified without any data and were based only on the general similarity of the chemical structure.']	chemical	CHEBI_EXT	[4618]	[4626]	PMC1168874_T49
PMC1168874	PMC1168874_39	[4638]	[4840]	['However, mild differences in the chemical structure can change the teratogenic potential, for example the teratogenic oxytetracyclines and non-teratogenic doxycycyline within the group of tetracyclines.']	chemical	CHEBI_EXT	[4671]	[4679]	PMC1168874_T50
PMC1168874	PMC1168874_39	[4638]	[4840]	['However, mild differences in the chemical structure can change the teratogenic potential, for example the teratogenic oxytetracyclines and non-teratogenic doxycycyline within the group of tetracyclines.']	oxytetracyclines	CHEBI_EXT	[4756]	[4772]	PMC1168874_T51
PMC1168874	PMC1168874_39	[4638]	[4840]	['However, mild differences in the chemical structure can change the teratogenic potential, for example the teratogenic oxytetracyclines and non-teratogenic doxycycyline within the group of tetracyclines.']	doxycycyline	CHEBI_EXT	[4793]	[4805]	PMC1168874_T52
PMC1168874	PMC1168874_39	[4638]	[4840]	['However, mild differences in the chemical structure can change the teratogenic potential, for example the teratogenic oxytetracyclines and non-teratogenic doxycycyline within the group of tetracyclines.']	tetracyclines	CHEBI_EXT	[4826]	[4839]	PMC1168874_T53
PMC1168874	PMC1168874_40	[4841]	[5074]	['At present the population-based Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA)11contains the largest national case-control data set in the world where the teratogenicity of about a hundred drugs was studied.']	drugs	CHEBI_EXT	[5056]	[5061]	PMC1168874_T54
PMC1168874	PMC1168874_41	[5075]	[5245]	['Our findings do not confirm the teratogenic risk of benzodiazepines such as diazepam12, chlordiazepoxide13, nitrazepam, medazepam, tofisopam, aplrazolum and clonazepam14.']	benzodiazepines	CHEBI_EXT	[5127]	[5142]	PMC1168874_T55
PMC1168874	PMC1168874_41	[5075]	[5245]	['Our findings do not confirm the teratogenic risk of benzodiazepines such as diazepam12, chlordiazepoxide13, nitrazepam, medazepam, tofisopam, aplrazolum and clonazepam14.']	diazepam12	CHEBI_EXT	[5151]	[5161]	PMC1168874_T56
PMC1168874	PMC1168874_41	[5075]	[5245]	['Our findings do not confirm the teratogenic risk of benzodiazepines such as diazepam12, chlordiazepoxide13, nitrazepam, medazepam, tofisopam, aplrazolum and clonazepam14.']	nitrazepam	CHEBI_EXT	[5183]	[5193]	PMC1168874_T57
PMC1168874	PMC1168874_41	[5075]	[5245]	['Our findings do not confirm the teratogenic risk of benzodiazepines such as diazepam12, chlordiazepoxide13, nitrazepam, medazepam, tofisopam, aplrazolum and clonazepam14.']	clonazepam14	CHEBI_EXT	[5232]	[5244]	PMC1168874_T58
PMC1168874	PMC1168874_42	[5246]	[5356]	['The teratogenic effect of diazepam and some other benzodiazepines was not confirmed after self-poisoning (i.e.']	diazepam	CHEBI_EXT	[5272]	[5280]	PMC1168874_T59
PMC1168874	PMC1168874_42	[5246]	[5356]	['The teratogenic effect of diazepam and some other benzodiazepines was not confirmed after self-poisoning (i.e.']	benzodiazepines	CHEBI_EXT	[5296]	[5311]	PMC1168874_T60
PMC1168874	PMC1168874_43	[5357]	[5406]	['suicide attempt) with extremely large doses15,16.']	suicide	GO_BP_EXT	[5357]	[5364]	PMC1168874_T257
PMC1168874	PMC1168874_44	[5407]	[5528]	['The teratogenic effect of barbitals17, furosemide18, aminoglycoside antibiotics19and povidone-iodine20was also not found.']	furosemide18	CHEBI_EXT	[5446]	[5458]	PMC1168874_T61
PMC1168874	PMC1168874_44	[5407]	[5528]	['The teratogenic effect of barbitals17, furosemide18, aminoglycoside antibiotics19and povidone-iodine20was also not found.']	aminoglycoside	CHEBI_EXT	[5460]	[5474]	PMC1168874_T62
PMC1168874	PMC1168874_44	[5407]	[5528]	['The teratogenic effect of barbitals17, furosemide18, aminoglycoside antibiotics19and povidone-iodine20was also not found.']	antibiotics19and	CHEBI_EXT	[5475]	[5491]	PMC1168874_T63
PMC1168874	PMC1168874_44	[5407]	[5528]	['The teratogenic effect of barbitals17, furosemide18, aminoglycoside antibiotics19and povidone-iodine20was also not found.']	povidone	CHEBI_EXT	[5492]	[5500]	PMC1168874_T64
PMC1168874	PMC1168874_44	[5407]	[5528]	['The teratogenic effect of barbitals17, furosemide18, aminoglycoside antibiotics19and povidone-iodine20was also not found.']	iodine20was	CHEBI_EXT	[5501]	[5512]	PMC1168874_T65
PMC1168874	PMC1168874_46	[5643]	[5793]	['Similar opinions were stated by other experts as well, therefore two other drug classification systems have been developed in Sweden21and Australia22.']	drug	CHEBI_EXT	[5718]	[5722]	PMC1168874_T66
PMC1168874	PMC1168874_47	[5794]	[5908]	['There are about 8,200 medicinal products in the Hungarian market, however, the number of chemical substances, i.e.']	medicinal	CHEBI_EXT	[5816]	[5825]	PMC1168874_T67
PMC1168874	PMC1168874_47	[5794]	[5908]	['There are about 8,200 medicinal products in the Hungarian market, however, the number of chemical substances, i.e.']	chemical	CHEBI_EXT	[5883]	[5891]	PMC1168874_T68
PMC1168874	PMC1168874_47	[5794]	[5908]	['There are about 8,200 medicinal products in the Hungarian market, however, the number of chemical substances, i.e.']	substances	CHEBI_EXT	[5892]	[5902]	PMC1168874_T69
PMC1168874	PMC1168874_48	[5909]	[5962]	['generic drugs with human teratogenic risk is limited.']	drugs	CHEBI_EXT	[5917]	[5922]	PMC1168874_T70
PMC1168874	PMC1168874_48	[5909]	[5962]	['generic drugs with human teratogenic risk is limited.']	human	NCBITAXON_EXT	[5928]	[5933]	PMC1168874_T390
PMC1168874	PMC1168874_49	[5963]	[6022]	['Table1shows drugs with high and moderate teratogenic risk .']	drugs	CHEBI_EXT	[5975]	[5980]	PMC1168874_T71
PMC1168874	PMC1168874_50	[6023]	[6177]	['Thalidomide was never marketed in Hungary, however, it is used again in some countries (e.g., Brazil) as an effective drug for leprosy and other diseases.']	Thalidomide	CHEBI_EXT	[6023]	[6034]	PMC1168874_T72
PMC1168874	PMC1168874_50	[6023]	[6177]	['Thalidomide was never marketed in Hungary, however, it is used again in some countries (e.g., Brazil) as an effective drug for leprosy and other diseases.']	drug	CHEBI_EXT	[6141]	[6145]	PMC1168874_T73
PMC1168874	PMC1168874_51	[6178]	[6377]	['Androgenic hormones are not indicated in the treatment of pregnant women, nevertheless some women used these drugs at the beginning of their unplanned pregnancies due to their body building activity.']	Androgenic	GO_MF_EXT	[6178]	[6188]	PMC1168874_T372
PMC1168874	PMC1168874_51	[6178]	[6377]	['Androgenic hormones are not indicated in the treatment of pregnant women, nevertheless some women used these drugs at the beginning of their unplanned pregnancies due to their body building activity.']	Androgenic hormones	CHEBI_EXT	[6178]	[6197]	PMC1168874_T74
PMC1168874	PMC1168874_51	[6178]	[6377]	['Androgenic hormones are not indicated in the treatment of pregnant women, nevertheless some women used these drugs at the beginning of their unplanned pregnancies due to their body building activity.']	hormones	CHEBI_EXT	[6189]	[6197]	PMC1168874_T373
PMC1168874	PMC1168874_51	[6178]	[6377]	['Androgenic hormones are not indicated in the treatment of pregnant women, nevertheless some women used these drugs at the beginning of their unplanned pregnancies due to their body building activity.']	pregnant	GO_BP_EXT	[6236]	[6244]	PMC1168874_T258
PMC1168874	PMC1168874_51	[6178]	[6377]	['Androgenic hormones are not indicated in the treatment of pregnant women, nevertheless some women used these drugs at the beginning of their unplanned pregnancies due to their body building activity.']	women	NCBITAXON_EXT	[6245]	[6250]	PMC1168874_T391
PMC1168874	PMC1168874_51	[6178]	[6377]	['Androgenic hormones are not indicated in the treatment of pregnant women, nevertheless some women used these drugs at the beginning of their unplanned pregnancies due to their body building activity.']	women	UBERON_EXT	[6245]	[6250]	PMC1168874_T451
PMC1168874	PMC1168874_51	[6178]	[6377]	['Androgenic hormones are not indicated in the treatment of pregnant women, nevertheless some women used these drugs at the beginning of their unplanned pregnancies due to their body building activity.']	women	NCBITAXON_EXT	[6270]	[6275]	PMC1168874_T392
PMC1168874	PMC1168874_51	[6178]	[6377]	['Androgenic hormones are not indicated in the treatment of pregnant women, nevertheless some women used these drugs at the beginning of their unplanned pregnancies due to their body building activity.']	women	UBERON_EXT	[6270]	[6275]	PMC1168874_T452
PMC1168874	PMC1168874_51	[6178]	[6377]	['Androgenic hormones are not indicated in the treatment of pregnant women, nevertheless some women used these drugs at the beginning of their unplanned pregnancies due to their body building activity.']	drugs	CHEBI_EXT	[6287]	[6292]	PMC1168874_T75
PMC1168874	PMC1168874_51	[6178]	[6377]	['Androgenic hormones are not indicated in the treatment of pregnant women, nevertheless some women used these drugs at the beginning of their unplanned pregnancies due to their body building activity.']	pregnancies	GO_BP_EXT	[6329]	[6340]	PMC1168874_T259
PMC1168874	PMC1168874_51	[6178]	[6377]	['Androgenic hormones are not indicated in the treatment of pregnant women, nevertheless some women used these drugs at the beginning of their unplanned pregnancies due to their body building activity.']	body	UBERON_EXT	[6354]	[6358]	PMC1168874_T453
PMC1168874	PMC1168874_52	[6378]	[6599]	['At present isotretinoin and etretinate are considered the most teratogenic risk used for the treatment of acne and psoriasis in Hungary, therefore an effective campaign was organized to prevent their use during pregnancy.']	teratogenic	CHEBI_EXT	[6441]	[6452]	PMC1168874_T76
PMC1168874	PMC1168874_52	[6378]	[6599]	['At present isotretinoin and etretinate are considered the most teratogenic risk used for the treatment of acne and psoriasis in Hungary, therefore an effective campaign was organized to prevent their use during pregnancy.']	pregnancy	GO_BP_EXT	[6589]	[6598]	PMC1168874_T260
PMC1168874	PMC1168874_53	[6600]	[6744]	['The coumarin derivatives cause the largest clinical problem because pregnant women with a previous thrombosis history frequently need treatment.']	coumarin	CHEBI_EXT	[6604]	[6612]	PMC1168874_T77
PMC1168874	PMC1168874_53	[6600]	[6744]	['The coumarin derivatives cause the largest clinical problem because pregnant women with a previous thrombosis history frequently need treatment.']	pregnant	GO_BP_EXT	[6668]	[6676]	PMC1168874_T261
PMC1168874	PMC1168874_53	[6600]	[6744]	['The coumarin derivatives cause the largest clinical problem because pregnant women with a previous thrombosis history frequently need treatment.']	women	NCBITAXON_EXT	[6677]	[6682]	PMC1168874_T393
PMC1168874	PMC1168874_53	[6600]	[6744]	['The coumarin derivatives cause the largest clinical problem because pregnant women with a previous thrombosis history frequently need treatment.']	women	UBERON_EXT	[6677]	[6682]	PMC1168874_T454
PMC1168874	PMC1168874_53	[6600]	[6744]	['The coumarin derivatives cause the largest clinical problem because pregnant women with a previous thrombosis history frequently need treatment.']	thrombosis	GO_BP_EXT	[6699]	[6709]	PMC1168874_T262
PMC1168874	PMC1168874_54	[6745]	[6958]	['However, it is possible to change the treatment protocol and use heparin instead of coumarin derivatives in the early pregnancy because the latter drugs are teratogenic in the third and fourth months of gestation.']	heparin	CHEBI_EXT	[6810]	[6817]	PMC1168874_T78
PMC1168874	PMC1168874_54	[6745]	[6958]	['However, it is possible to change the treatment protocol and use heparin instead of coumarin derivatives in the early pregnancy because the latter drugs are teratogenic in the third and fourth months of gestation.']	coumarin	CHEBI_EXT	[6829]	[6837]	PMC1168874_T79
PMC1168874	PMC1168874_54	[6745]	[6958]	['However, it is possible to change the treatment protocol and use heparin instead of coumarin derivatives in the early pregnancy because the latter drugs are teratogenic in the third and fourth months of gestation.']	pregnancy	GO_BP_EXT	[6863]	[6872]	PMC1168874_T263
PMC1168874	PMC1168874_54	[6745]	[6958]	['However, it is possible to change the treatment protocol and use heparin instead of coumarin derivatives in the early pregnancy because the latter drugs are teratogenic in the third and fourth months of gestation.']	drugs	CHEBI_EXT	[6892]	[6897]	PMC1168874_T80
PMC1168874	PMC1168874_54	[6745]	[6958]	['However, it is possible to change the treatment protocol and use heparin instead of coumarin derivatives in the early pregnancy because the latter drugs are teratogenic in the third and fourth months of gestation.']	gestation	GO_BP_EXT	[6948]	[6957]	PMC1168874_T264
PMC1168874	PMC1168874_55	[6959]	[7043]	['Oxytetracyclines are also teratogenic, but these products are now not on the market.']	Oxytetracyclines	CHEBI_EXT	[6959]	[6975]	PMC1168874_T81
PMC1168874	PMC1168874_56	[7044]	[7307]	['The use of oxytetracyclines was relatively frequent in Hungarian pregnant women, thus we were able to show that Tetran®induced – other than staining of deciduous teeth – a characteristic pattern of multiple CA23.On the other hand doxycycline is not teratogenic24.']	oxytetracyclines	CHEBI_EXT	[7055]	[7071]	PMC1168874_T82
PMC1168874	PMC1168874_56	[7044]	[7307]	['The use of oxytetracyclines was relatively frequent in Hungarian pregnant women, thus we were able to show that Tetran®induced – other than staining of deciduous teeth – a characteristic pattern of multiple CA23.On the other hand doxycycline is not teratogenic24.']	pregnant	GO_BP_EXT	[7109]	[7117]	PMC1168874_T265
PMC1168874	PMC1168874_56	[7044]	[7307]	['The use of oxytetracyclines was relatively frequent in Hungarian pregnant women, thus we were able to show that Tetran®induced – other than staining of deciduous teeth – a characteristic pattern of multiple CA23.On the other hand doxycycline is not teratogenic24.']	women	NCBITAXON_EXT	[7118]	[7123]	PMC1168874_T394
PMC1168874	PMC1168874_56	[7044]	[7307]	['The use of oxytetracyclines was relatively frequent in Hungarian pregnant women, thus we were able to show that Tetran®induced – other than staining of deciduous teeth – a characteristic pattern of multiple CA23.On the other hand doxycycline is not teratogenic24.']	women	UBERON_EXT	[7118]	[7123]	PMC1168874_T455
PMC1168874	PMC1168874_56	[7044]	[7307]	['The use of oxytetracyclines was relatively frequent in Hungarian pregnant women, thus we were able to show that Tetran®induced – other than staining of deciduous teeth – a characteristic pattern of multiple CA23.On the other hand doxycycline is not teratogenic24.']	Tetran	CHEBI_EXT	[7156]	[7162]	PMC1168874_T83
PMC1168874	PMC1168874_56	[7044]	[7307]	['The use of oxytetracyclines was relatively frequent in Hungarian pregnant women, thus we were able to show that Tetran®induced – other than staining of deciduous teeth – a characteristic pattern of multiple CA23.On the other hand doxycycline is not teratogenic24.']	deciduous teeth	UBERON_EXT	[7196]	[7211]	PMC1168874_T456
PMC1168874	PMC1168874_56	[7044]	[7307]	['The use of oxytetracyclines was relatively frequent in Hungarian pregnant women, thus we were able to show that Tetran®induced – other than staining of deciduous teeth – a characteristic pattern of multiple CA23.On the other hand doxycycline is not teratogenic24.']	doxycycline	CHEBI_EXT	[7274]	[7285]	PMC1168874_T84
PMC1168874	PMC1168874_57	[7308]	[7340]	['The use of D-penicillamine (e.g.']	D-penicillamine	CHEBI_EXT	[7319]	[7334]	PMC1168874_T85
PMC1168874	PMC1168874_58	[7341]	[7419]	['in Wilson disease) rarely occurs and it may cause cutis laxa, not a severe CA.']	cutis	UBERON_EXT	[7391]	[7396]	PMC1168874_T457
PMC1168874	PMC1168874_59	[7420]	[7486]	['In addition this CA can be diminished by the parallel use of zinc.']	zinc	CHEBI_EXT	[7481]	[7485]	PMC1168874_T86
PMC1168874	PMC1168874_60	[7487]	[7541]	['Diethylstilbestrol was also withdrawn from the market.']	Diethylstilbestrol	CHEBI_EXT	[7487]	[7505]	PMC1168874_T87
PMC1168874	PMC1168874_61	[7542]	[7781]	['The proportion of women treated with drugs with high and moderate teratogenic risk during the study pregnancy was 0.8% and 0.4% in the group of cases with CAs and controls without CAs in the data set of the HCCSCA, 1980-2002, respectively.']	women	NCBITAXON_EXT	[7560]	[7565]	PMC1168874_T395
PMC1168874	PMC1168874_61	[7542]	[7781]	['The proportion of women treated with drugs with high and moderate teratogenic risk during the study pregnancy was 0.8% and 0.4% in the group of cases with CAs and controls without CAs in the data set of the HCCSCA, 1980-2002, respectively.']	women	UBERON_EXT	[7560]	[7565]	PMC1168874_T458
PMC1168874	PMC1168874_61	[7542]	[7781]	['The proportion of women treated with drugs with high and moderate teratogenic risk during the study pregnancy was 0.8% and 0.4% in the group of cases with CAs and controls without CAs in the data set of the HCCSCA, 1980-2002, respectively.']	drugs	CHEBI_EXT	[7579]	[7584]	PMC1168874_T88
PMC1168874	PMC1168874_61	[7542]	[7781]	['The proportion of women treated with drugs with high and moderate teratogenic risk during the study pregnancy was 0.8% and 0.4% in the group of cases with CAs and controls without CAs in the data set of the HCCSCA, 1980-2002, respectively.']	teratogenic	GO_BP_EXT	[7608]	[7619]	PMC1168874_T266
PMC1168874	PMC1168874_61	[7542]	[7781]	['The proportion of women treated with drugs with high and moderate teratogenic risk during the study pregnancy was 0.8% and 0.4% in the group of cases with CAs and controls without CAs in the data set of the HCCSCA, 1980-2002, respectively.']	pregnancy	GO_BP_EXT	[7642]	[7651]	PMC1168874_T267
PMC1168874	PMC1168874_62	[7782]	[8074]	['The list of drugs with low and very low teratogenic risk is longer (Table2), though the names of drugs with fetotoxic effects, e.g., chlorothiazide, angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, reversible goiter inducing potassium iodine, etc, are not mentioned.']	drugs	CHEBI_EXT	[7794]	[7799]	PMC1168874_T89
PMC1168874	PMC1168874_62	[7782]	[8074]	['The list of drugs with low and very low teratogenic risk is longer (Table2), though the names of drugs with fetotoxic effects, e.g., chlorothiazide, angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, reversible goiter inducing potassium iodine, etc, are not mentioned.']	drugs	CHEBI_EXT	[7879]	[7884]	PMC1168874_T90
PMC1168874	PMC1168874_62	[7782]	[8074]	['The list of drugs with low and very low teratogenic risk is longer (Table2), though the names of drugs with fetotoxic effects, e.g., chlorothiazide, angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, reversible goiter inducing potassium iodine, etc, are not mentioned.']	chlorothiazide	CHEBI_EXT	[7915]	[7929]	PMC1168874_T91
PMC1168874	PMC1168874_62	[7782]	[8074]	['The list of drugs with low and very low teratogenic risk is longer (Table2), though the names of drugs with fetotoxic effects, e.g., chlorothiazide, angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, reversible goiter inducing potassium iodine, etc, are not mentioned.']	angiotensin-converting enzyme	PR_EXT	[7931]	[7960]	PMC1168874_T430
PMC1168874	PMC1168874_62	[7782]	[8074]	['The list of drugs with low and very low teratogenic risk is longer (Table2), though the names of drugs with fetotoxic effects, e.g., chlorothiazide, angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, reversible goiter inducing potassium iodine, etc, are not mentioned.']	angiotensin-converting enzyme inhibitors	CHEBI_EXT	[7931]	[7971]	PMC1168874_T92
PMC1168874	PMC1168874_62	[7782]	[8074]	['The list of drugs with low and very low teratogenic risk is longer (Table2), though the names of drugs with fetotoxic effects, e.g., chlorothiazide, angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, reversible goiter inducing potassium iodine, etc, are not mentioned.']	angiotensin-converting enzyme inhibitors	GO_MF_EXT	[7931]	[7971]	PMC1168874_T374
PMC1168874	PMC1168874_62	[7782]	[8074]	['The list of drugs with low and very low teratogenic risk is longer (Table2), though the names of drugs with fetotoxic effects, e.g., chlorothiazide, angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, reversible goiter inducing potassium iodine, etc, are not mentioned.']	enzyme	CHEBI_EXT	[7954]	[7960]	PMC1168874_T434
PMC1168874	PMC1168874_62	[7782]	[8074]	['The list of drugs with low and very low teratogenic risk is longer (Table2), though the names of drugs with fetotoxic effects, e.g., chlorothiazide, angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, reversible goiter inducing potassium iodine, etc, are not mentioned.']	beta-adrenergic	GO_MF_EXT	[7973]	[7988]	PMC1168874_T431
PMC1168874	PMC1168874_62	[7782]	[8074]	['The list of drugs with low and very low teratogenic risk is longer (Table2), though the names of drugs with fetotoxic effects, e.g., chlorothiazide, angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, reversible goiter inducing potassium iodine, etc, are not mentioned.']	beta-adrenergic	GO_MF_EXT	[7973]	[7988]	PMC1168874_T375
PMC1168874	PMC1168874_62	[7782]	[8074]	['The list of drugs with low and very low teratogenic risk is longer (Table2), though the names of drugs with fetotoxic effects, e.g., chlorothiazide, angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, reversible goiter inducing potassium iodine, etc, are not mentioned.']	adrenergic blocking agents	CHEBI_EXT	[7978]	[8004]	PMC1168874_T93
PMC1168874	PMC1168874_62	[7782]	[8074]	['The list of drugs with low and very low teratogenic risk is longer (Table2), though the names of drugs with fetotoxic effects, e.g., chlorothiazide, angiotensin-converting enzyme inhibitors, beta-adrenergic blocking agents, reversible goiter inducing potassium iodine, etc, are not mentioned.']	potassium iodine	CHEBI_EXT	[8033]	[8049]	PMC1168874_T94
PMC1168874	PMC1168874_63	[8075]	[8201]	['There is a long list of antineoplastic and anticonvulsant drugs which may be needed in pregnant women with cancer or epilepsy.']	antineoplastic ...	CHEBI_EXT	[8099]	[8113]	PMC1168874_T95
PMC1168874	PMC1168874_63	[8075]	[8201]	['There is a long list of antineoplastic and anticonvulsant drugs which may be needed in pregnant women with cancer or epilepsy.']	anticonvulsant	CHEBI_EXT	[8118]	[8132]	PMC1168874_T96
PMC1168874	PMC1168874_63	[8075]	[8201]	['There is a long list of antineoplastic and anticonvulsant drugs which may be needed in pregnant women with cancer or epilepsy.']	drugs	CHEBI_EXT	[8133]	[8138]	PMC1168874_T97
PMC1168874	PMC1168874_63	[8075]	[8201]	['There is a long list of antineoplastic and anticonvulsant drugs which may be needed in pregnant women with cancer or epilepsy.']	pregnant	GO_BP_EXT	[8162]	[8170]	PMC1168874_T268
PMC1168874	PMC1168874_63	[8075]	[8201]	['There is a long list of antineoplastic and anticonvulsant drugs which may be needed in pregnant women with cancer or epilepsy.']	women	NCBITAXON_EXT	[8171]	[8176]	PMC1168874_T396
PMC1168874	PMC1168874_63	[8075]	[8201]	['There is a long list of antineoplastic and anticonvulsant drugs which may be needed in pregnant women with cancer or epilepsy.']	women	UBERON_EXT	[8171]	[8176]	PMC1168874_T459
PMC1168874	PMC1168874_64	[8202]	[8318]	['At present some of them are not on the market, but most drugs in this list have a teratogenic risk between 2 and 5%.']	drugs	CHEBI_EXT	[8258]	[8263]	PMC1168874_T98
PMC1168874	PMC1168874_65	[8319]	[8384]	['Ergotamine and quinine derivatives were used relatively frequent.']	Ergotamine	CHEBI_EXT	[8319]	[8329]	PMC1168874_T99
PMC1168874	PMC1168874_65	[8319]	[8384]	['Ergotamine and quinine derivatives were used relatively frequent.']	quinine	CHEBI_EXT	[8334]	[8341]	PMC1168874_T100
PMC1168874	PMC1168874_66	[8385]	[8468]	['Among oestrogens and retinol (vitamin A), only high dose treatments are considered.']	oestrogens	CHEBI_EXT	[8391]	[8401]	PMC1168874_T101
PMC1168874	PMC1168874_66	[8385]	[8468]	['Among oestrogens and retinol (vitamin A), only high dose treatments are considered.']	retinol	CHEBI_EXT	[8406]	[8413]	PMC1168874_T102
PMC1168874	PMC1168874_66	[8385]	[8468]	['Among oestrogens and retinol (vitamin A), only high dose treatments are considered.']	vitamin A	CHEBI_EXT	[8415]	[8424]	PMC1168874_T103
PMC1168874	PMC1168874_67	[8469]	[8698]	['It is worth mentioning that we had three mothers who were treated by 50,000 and one with 100,000 IU doses of vitamin A daily in the first and second months of gestation, and later they delivered newborn infants without any CAs25.']	vitamin A	CHEBI_EXT	[8578]	[8587]	PMC1168874_T104
PMC1168874	PMC1168874_67	[8469]	[8698]	['It is worth mentioning that we had three mothers who were treated by 50,000 and one with 100,000 IU doses of vitamin A daily in the first and second months of gestation, and later they delivered newborn infants without any CAs25.']	gestation	GO_BP_EXT	[8628]	[8637]	PMC1168874_T269
PMC1168874	PMC1168874_67	[8469]	[8698]	['It is worth mentioning that we had three mothers who were treated by 50,000 and one with 100,000 IU doses of vitamin A daily in the first and second months of gestation, and later they delivered newborn infants without any CAs25.']	delivered	GO_BP_EXT	[8654]	[8663]	PMC1168874_T270
PMC1168874	PMC1168874_67	[8469]	[8698]	['It is worth mentioning that we had three mothers who were treated by 50,000 and one with 100,000 IU doses of vitamin A daily in the first and second months of gestation, and later they delivered newborn infants without any CAs25.']	newborn	UBERON_EXT	[8664]	[8671]	PMC1168874_T460
PMC1168874	PMC1168874_67	[8469]	[8698]	['It is worth mentioning that we had three mothers who were treated by 50,000 and one with 100,000 IU doses of vitamin A daily in the first and second months of gestation, and later they delivered newborn infants without any CAs25.']	infants	UBERON_EXT	[8672]	[8679]	PMC1168874_T461
PMC1168874	PMC1168874_68	[8699]	[8996]	['Our finding is in agreement with the conclusion of the European Network of the Teratology Information Services, whose data set did not provide evidence for an increased risk of major CAs associated with high vitamin A intake (10,000 IU per day or more) during the organogenetic period of embryo26.']	vitamin A	CHEBI_EXT	[8907]	[8916]	PMC1168874_T105
PMC1168874	PMC1168874_68	[8699]	[8996]	['Our finding is in agreement with the conclusion of the European Network of the Teratology Information Services, whose data set did not provide evidence for an increased risk of major CAs associated with high vitamin A intake (10,000 IU per day or more) during the organogenetic period of embryo26.']	organogenetic	GO_BP_EXT	[8963]	[8976]	PMC1168874_T271
PMC1168874	PMC1168874_68	[8699]	[8996]	['Our finding is in agreement with the conclusion of the European Network of the Teratology Information Services, whose data set did not provide evidence for an increased risk of major CAs associated with high vitamin A intake (10,000 IU per day or more) during the organogenetic period of embryo26.']	embryo26	UBERON_EXT	[8987]	[8995]	PMC1168874_T462
PMC1168874	PMC1168874_69	[8997]	[9081]	['Here we discuss three problems at the evaluation of human teratogenic risk of drugs.']	human	NCBITAXON_EXT	[9049]	[9054]	PMC1168874_T397
PMC1168874	PMC1168874_69	[8997]	[9081]	['Here we discuss three problems at the evaluation of human teratogenic risk of drugs.']	drugs	CHEBI_EXT	[9075]	[9080]	PMC1168874_T106
PMC1168874	PMC1168874_71	[9086]	[9306]	['Low scientific quality of previous human teratogenic studies\nUnfortunately the scientific quality of most previous studies regarding risk estimation of teratogenic medications was low due to some methodological problems.']	human	NCBITAXON_EXT	[9121]	[9126]	PMC1168874_T398
PMC1168874	PMC1168874_71	[9086]	[9306]	['Low scientific quality of previous human teratogenic studies\nUnfortunately the scientific quality of most previous studies regarding risk estimation of teratogenic medications was low due to some methodological problems.']	teratogenic	CHEBI_EXT	[9127]	[9138]	PMC1168874_T107
PMC1168874	PMC1168874_71	[9086]	[9306]	['Low scientific quality of previous human teratogenic studies\nUnfortunately the scientific quality of most previous studies regarding risk estimation of teratogenic medications was low due to some methodological problems.']	teratogenic	CHEBI_EXT	[9238]	[9249]	PMC1168874_T108
PMC1168874	PMC1168874_71	[9086]	[9306]	['Low scientific quality of previous human teratogenic studies\nUnfortunately the scientific quality of most previous studies regarding risk estimation of teratogenic medications was low due to some methodological problems.']	medications	CHEBI_EXT	[9250]	[9261]	PMC1168874_T109
PMC1168874	PMC1168874_72	[9308]	[9446]	['Time factor: first trimester concept is outdated\nThe first trimester of pregnancy was considered as the critical period of most major CAs.']	trimester	GO_BP_EXT	[9327]	[9336]	PMC1168874_T272
PMC1168874	PMC1168874_72	[9308]	[9446]	['Time factor: first trimester concept is outdated\nThe first trimester of pregnancy was considered as the critical period of most major CAs.']	trimester of pregnancy	GO_BP_EXT	[9367]	[9389]	PMC1168874_T273
PMC1168874	PMC1168874_74	[9496]	[9583]	['At present gestation age is calculated from the first day of the last menstrual period.']	gestation	GO_BP_EXT	[9507]	[9516]	PMC1168874_T274
PMC1168874	PMC1168874_74	[9496]	[9583]	['At present gestation age is calculated from the first day of the last menstrual period.']	menstrual	GO_BP_EXT	[9566]	[9575]	PMC1168874_T275
PMC1168874	PMC1168874_74	[9496]	[9583]	['At present gestation age is calculated from the first day of the last menstrual period.']	menstrual period	UBERON_EXT	[9566]	[9582]	PMC1168874_T463
PMC1168874	PMC1168874_75	[9584]	[9668]	['Thus, “pregnant women” are not pregnant in the first two weeks of their pregnancies.']	pregnant	GO_BP_EXT	[9591]	[9599]	PMC1168874_T276
PMC1168874	PMC1168874_75	[9584]	[9668]	['Thus, “pregnant women” are not pregnant in the first two weeks of their pregnancies.']	women	NCBITAXON_EXT	[9600]	[9605]	PMC1168874_T399
PMC1168874	PMC1168874_75	[9584]	[9668]	['Thus, “pregnant women” are not pregnant in the first two weeks of their pregnancies.']	pregnant	GO_BP_EXT	[9615]	[9623]	PMC1168874_T277
PMC1168874	PMC1168874_75	[9584]	[9668]	['Thus, “pregnant women” are not pregnant in the first two weeks of their pregnancies.']	pregnancies	GO_BP_EXT	[9656]	[9667]	PMC1168874_T278
PMC1168874	PMC1168874_76	[9669]	[9797]	['The third week covers the preimplantation period when the zygote goes from the external end of the Fallopian tube to the uterus.']	preimplantation	GO_BP_EXT	[9695]	[9710]	PMC1168874_T279
PMC1168874	PMC1168874_76	[9669]	[9797]	['The third week covers the preimplantation period when the zygote goes from the external end of the Fallopian tube to the uterus.']	zygote	CL_EXT	[9727]	[9733]	PMC1168874_T228
PMC1168874	PMC1168874_76	[9669]	[9797]	['The third week covers the preimplantation period when the zygote goes from the external end of the Fallopian tube to the uterus.']	Fallopian tube	UBERON_EXT	[9768]	[9782]	PMC1168874_T464
PMC1168874	PMC1168874_76	[9669]	[9797]	['The third week covers the preimplantation period when the zygote goes from the external end of the Fallopian tube to the uterus.']	uterus	UBERON_EXT	[9790]	[9796]	PMC1168874_T465
PMC1168874	PMC1168874_77	[9798]	[9897]	['The fourth week comprises the implantation period when the blastocyst finds its site in the uterus.']	implantation	GO_BP_EXT	[9828]	[9840]	PMC1168874_T280
PMC1168874	PMC1168874_77	[9798]	[9897]	['The fourth week comprises the implantation period when the blastocyst finds its site in the uterus.']	blastocyst	UBERON_EXT	[9857]	[9867]	PMC1168874_T466
PMC1168874	PMC1168874_77	[9798]	[9897]	['The fourth week comprises the implantation period when the blastocyst finds its site in the uterus.']	uterus	UBERON_EXT	[9890]	[9896]	PMC1168874_T467
PMC1168874	PMC1168874_78	[9898]	[10010]	['However, the zygotes and blastocysts have continuous mitoses producing totipotent stem cells during this period.']	zygotes	CL_EXT	[9911]	[9918]	PMC1168874_T229
PMC1168874	PMC1168874_78	[9898]	[10010]	['However, the zygotes and blastocysts have continuous mitoses producing totipotent stem cells during this period.']	zygotes	UBERON_EXT	[9911]	[9918]	PMC1168874_T468
PMC1168874	PMC1168874_78	[9898]	[10010]	['However, the zygotes and blastocysts have continuous mitoses producing totipotent stem cells during this period.']	blastocysts	UBERON_EXT	[9923]	[9934]	PMC1168874_T469
PMC1168874	PMC1168874_78	[9898]	[10010]	['However, the zygotes and blastocysts have continuous mitoses producing totipotent stem cells during this period.']	totipotent	CL_EXT	[9969]	[9979]	PMC1168874_T230
PMC1168874	PMC1168874_78	[9898]	[10010]	['However, the zygotes and blastocysts have continuous mitoses producing totipotent stem cells during this period.']	stem cells	CL_EXT	[9980]	[9990]	PMC1168874_T231
PMC1168874	PMC1168874_78	[9898]	[10010]	['However, the zygotes and blastocysts have continuous mitoses producing totipotent stem cells during this period.']	cells	CL_EXT	[9985]	[9990]	PMC1168874_T363
PMC1168874	PMC1168874_79	[10011]	[10104]	['Serious damage can cause their death, but after limited damage they have a complete recovery.']	death	GO_BP_EXT	[10042]	[10047]	PMC1168874_T281
PMC1168874	PMC1168874_80	[10105]	[10357]	['These facts explain the rule of “all-or-nothing effect” or in other words the consequence of these damages have only two outcomes: complete loss of zygotes/blastocysts (which causes only some delay in the seemingly menstrual bleeding) or healthy birth.']	zygotes	CL_EXT	[10253]	[10260]	PMC1168874_T232
PMC1168874	PMC1168874_80	[10105]	[10357]	['These facts explain the rule of “all-or-nothing effect” or in other words the consequence of these damages have only two outcomes: complete loss of zygotes/blastocysts (which causes only some delay in the seemingly menstrual bleeding) or healthy birth.']	blastocysts	UBERON_EXT	[10261]	[10272]	PMC1168874_T470
PMC1168874	PMC1168874_80	[10105]	[10357]	['These facts explain the rule of “all-or-nothing effect” or in other words the consequence of these damages have only two outcomes: complete loss of zygotes/blastocysts (which causes only some delay in the seemingly menstrual bleeding) or healthy birth.']	menstrual	GO_BP_EXT	[10320]	[10329]	PMC1168874_T282
PMC1168874	PMC1168874_80	[10105]	[10357]	['These facts explain the rule of “all-or-nothing effect” or in other words the consequence of these damages have only two outcomes: complete loss of zygotes/blastocysts (which causes only some delay in the seemingly menstrual bleeding) or healthy birth.']	menstrual	UBERON_EXT	[10320]	[10329]	PMC1168874_T471
PMC1168874	PMC1168874_80	[10105]	[10357]	['These facts explain the rule of “all-or-nothing effect” or in other words the consequence of these damages have only two outcomes: complete loss of zygotes/blastocysts (which causes only some delay in the seemingly menstrual bleeding) or healthy birth.']	birth	GO_BP_EXT	[10351]	[10356]	PMC1168874_T283
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	human	NCBITAXON_EXT	[10373]	[10378]	PMC1168874_T400
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	teratogenic	CHEBI_EXT	[10379]	[10390]	PMC1168874_T110
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	drugs	CHEBI_EXT	[10391]	[10396]	PMC1168874_T111
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	gestation	GO_BP_EXT	[10436]	[10445]	PMC1168874_T284
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	DNA	CHEBI_EXT	[10481]	[10484]	PMC1168874_T112
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	DNA	CHEBI_EXT	[10481]	[10484]	PMC1168874_T435
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	stem cells	CL_EXT	[10492]	[10502]	PMC1168874_T233
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	cells	CL_EXT	[10497]	[10502]	PMC1168874_T364
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	differentiation of ... cells	GO_BP_EXT	[10521, 10549]	[10539, 10554]	PMC1168874_T285
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	cells	CL_EXT	[10549]	[10554]	PMC1168874_T234
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	cells	CL_EXT	[10549]	[10554]	PMC1168874_T365
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	organs	UBERON_EXT	[10556]	[10562]	PMC1168874_T472
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	body	UBERON_EXT	[10567]	[10571]	PMC1168874_T473
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	gestation	GO_BP_EXT	[10604]	[10613]	PMC1168874_T286
PMC1168874	PMC1168874_81	[10358]	[10650]	['In conclusion, human teratogenic drugs cannot induce CA in the first month of gestation because the specific activation of DNA in the stem cells and the so-called differentiation of specific cells, organs and body forms starts on the 29th day of gestation (or on the 15th postconception day).']	postconception	GO_BP_EXT	[10630]	[10644]	PMC1168874_T287
PMC1168874	PMC1168874_82	[10651]	[10786]	['The 29th day of gestation overlaps with the first days of missing menstrual bleeding when women in general can recognize the pregnancy.']	gestation	GO_BP_EXT	[10667]	[10676]	PMC1168874_T288
PMC1168874	PMC1168874_82	[10651]	[10786]	['The 29th day of gestation overlaps with the first days of missing menstrual bleeding when women in general can recognize the pregnancy.']	menstrual	GO_BP_EXT	[10717]	[10726]	PMC1168874_T289
PMC1168874	PMC1168874_82	[10651]	[10786]	['The 29th day of gestation overlaps with the first days of missing menstrual bleeding when women in general can recognize the pregnancy.']	menstrual	UBERON_EXT	[10717]	[10726]	PMC1168874_T474
PMC1168874	PMC1168874_82	[10651]	[10786]	['The 29th day of gestation overlaps with the first days of missing menstrual bleeding when women in general can recognize the pregnancy.']	women	NCBITAXON_EXT	[10741]	[10746]	PMC1168874_T401
PMC1168874	PMC1168874_82	[10651]	[10786]	['The 29th day of gestation overlaps with the first days of missing menstrual bleeding when women in general can recognize the pregnancy.']	pregnancy	GO_BP_EXT	[10776]	[10785]	PMC1168874_T290
PMC1168874	PMC1168874_83	[10787]	[10906]	['Thus, it is necessary to know that before the first missed menstrual bleeding, environmental factors cannot induce CAs.']	menstrual	GO_BP_EXT	[10846]	[10855]	PMC1168874_T291
PMC1168874	PMC1168874_83	[10787]	[10906]	['Thus, it is necessary to know that before the first missed menstrual bleeding, environmental factors cannot induce CAs.']	menstrual	UBERON_EXT	[10846]	[10855]	PMC1168874_T475
PMC1168874	PMC1168874_84	[10907]	[10990]	['The main organ-forming period lasts from the 29th day to the 70th day of gestation.']	organ	UBERON_EXT	[10916]	[10921]	PMC1168874_T476
PMC1168874	PMC1168874_84	[10907]	[10990]	['The main organ-forming period lasts from the 29th day to the 70th day of gestation.']	gestation	GO_BP_EXT	[10980]	[10989]	PMC1168874_T292
PMC1168874	PMC1168874_86	[11156]	[11501]	['On the other hand we know that the critical period of some CAs exceeds the end of third month, e.g., the critical period of posterior cleft palate and hypospadias covers the 12th-14th and 14th-16th weeks of gestation, while the critical period of undescended testis and patent ductus arteriosus is 7 to 9 months and 9 to 10 months, respectively.']	palate	UBERON_EXT	[11296]	[11302]	PMC1168874_T477
PMC1168874	PMC1168874_86	[11156]	[11501]	['On the other hand we know that the critical period of some CAs exceeds the end of third month, e.g., the critical period of posterior cleft palate and hypospadias covers the 12th-14th and 14th-16th weeks of gestation, while the critical period of undescended testis and patent ductus arteriosus is 7 to 9 months and 9 to 10 months, respectively.']	gestation	GO_BP_EXT	[11363]	[11372]	PMC1168874_T293
PMC1168874	PMC1168874_86	[11156]	[11501]	['On the other hand we know that the critical period of some CAs exceeds the end of third month, e.g., the critical period of posterior cleft palate and hypospadias covers the 12th-14th and 14th-16th weeks of gestation, while the critical period of undescended testis and patent ductus arteriosus is 7 to 9 months and 9 to 10 months, respectively.']	testis	UBERON_EXT	[11415]	[11421]	PMC1168874_T478
PMC1168874	PMC1168874_86	[11156]	[11501]	['On the other hand we know that the critical period of some CAs exceeds the end of third month, e.g., the critical period of posterior cleft palate and hypospadias covers the 12th-14th and 14th-16th weeks of gestation, while the critical period of undescended testis and patent ductus arteriosus is 7 to 9 months and 9 to 10 months, respectively.']	ductus arteriosus	UBERON_EXT	[11433]	[11450]	PMC1168874_T479
PMC1168874	PMC1168874_89	[11723]	[11869]	['Therefore we have to focus our analysis on specific CAs since teratogenic drugs induce specific CAs without affecting other CAs and overall rates.']	teratogenic	CHEBI_EXT	[11785]	[11796]	PMC1168874_T113
PMC1168874	PMC1168874_89	[11723]	[11869]	['Therefore we have to focus our analysis on specific CAs since teratogenic drugs induce specific CAs without affecting other CAs and overall rates.']	teratogenic	GO_BP_EXT	[11785]	[11796]	PMC1168874_T294
PMC1168874	PMC1168874_89	[11723]	[11869]	['Therefore we have to focus our analysis on specific CAs since teratogenic drugs induce specific CAs without affecting other CAs and overall rates.']	drugs	CHEBI_EXT	[11797]	[11802]	PMC1168874_T114
PMC1168874	PMC1168874_90	[11870]	[11951]	['Thus, we have to do our best to develop groups of CAs as homogeneous as possible.']	groups of CAs	UBERON_EXT	[11910]	[11923]	PMC1168874_T480
PMC1168874	PMC1168874_91	[11952]	[12066]	['In addition the most teratogenic drugs cause specific CA syndromes with a characteristic pattern of component CAs.']	teratogenic	CHEBI_EXT	[11973]	[11984]	PMC1168874_T115
PMC1168874	PMC1168874_91	[11952]	[12066]	['In addition the most teratogenic drugs cause specific CA syndromes with a characteristic pattern of component CAs.']	drugs	CHEBI_EXT	[11985]	[11990]	PMC1168874_T116
PMC1168874	PMC1168874_92	[12067]	[12200]	['This phenomenon explains the delineation of fetal alcohol, radiation, rubella, hydantoin-phenytoin, warfarin-coumarin, accutane, etc.']	alcohol	CHEBI_EXT	[12117]	[12124]	PMC1168874_T117
PMC1168874	PMC1168874_92	[12067]	[12200]	['This phenomenon explains the delineation of fetal alcohol, radiation, rubella, hydantoin-phenytoin, warfarin-coumarin, accutane, etc.']	hydantoin	CHEBI_EXT	[12146]	[12155]	PMC1168874_T118
PMC1168874	PMC1168874_92	[12067]	[12200]	['This phenomenon explains the delineation of fetal alcohol, radiation, rubella, hydantoin-phenytoin, warfarin-coumarin, accutane, etc.']	phenytoin	CHEBI_EXT	[12156]	[12165]	PMC1168874_T119
PMC1168874	PMC1168874_92	[12067]	[12200]	['This phenomenon explains the delineation of fetal alcohol, radiation, rubella, hydantoin-phenytoin, warfarin-coumarin, accutane, etc.']	coumarin	CHEBI_EXT	[12176]	[12184]	PMC1168874_T120
PMC1168874	PMC1168874_92	[12067]	[12200]	['This phenomenon explains the delineation of fetal alcohol, radiation, rubella, hydantoin-phenytoin, warfarin-coumarin, accutane, etc.']	accutane	CHEBI_EXT	[12186]	[12194]	PMC1168874_T121
PMC1168874	PMC1168874_94	[12212]	[12461]	['This rule helps us to identify the cause of specific CA-syndrome, e.g., if a case is affected with cleft lip and nail hypoplasia, we can diagnose hydantoin (phenytoin) CA-syndrome in a baby of an epileptic mother who has been treated with this drug.']	lip	UBERON_EXT	[12317]	[12320]	PMC1168874_T481
PMC1168874	PMC1168874_94	[12212]	[12461]	['This rule helps us to identify the cause of specific CA-syndrome, e.g., if a case is affected with cleft lip and nail hypoplasia, we can diagnose hydantoin (phenytoin) CA-syndrome in a baby of an epileptic mother who has been treated with this drug.']	nail	UBERON_EXT	[12325]	[12329]	PMC1168874_T482
PMC1168874	PMC1168874_94	[12212]	[12461]	['This rule helps us to identify the cause of specific CA-syndrome, e.g., if a case is affected with cleft lip and nail hypoplasia, we can diagnose hydantoin (phenytoin) CA-syndrome in a baby of an epileptic mother who has been treated with this drug.']	hydantoin	CHEBI_EXT	[12358]	[12367]	PMC1168874_T122
PMC1168874	PMC1168874_94	[12212]	[12461]	['This rule helps us to identify the cause of specific CA-syndrome, e.g., if a case is affected with cleft lip and nail hypoplasia, we can diagnose hydantoin (phenytoin) CA-syndrome in a baby of an epileptic mother who has been treated with this drug.']	phenytoin	CHEBI_EXT	[12369]	[12378]	PMC1168874_T123
PMC1168874	PMC1168874_94	[12212]	[12461]	['This rule helps us to identify the cause of specific CA-syndrome, e.g., if a case is affected with cleft lip and nail hypoplasia, we can diagnose hydantoin (phenytoin) CA-syndrome in a baby of an epileptic mother who has been treated with this drug.']	baby	UBERON_EXT	[12397]	[12401]	PMC1168874_T483
PMC1168874	PMC1168874_94	[12212]	[12461]	['This rule helps us to identify the cause of specific CA-syndrome, e.g., if a case is affected with cleft lip and nail hypoplasia, we can diagnose hydantoin (phenytoin) CA-syndrome in a baby of an epileptic mother who has been treated with this drug.']	drug	CHEBI_EXT	[12456]	[12460]	PMC1168874_T124
PMC1168874	PMC1168874_96	[12643]	[12773]	['Most isolated CAs have a complex etiology based on some polygenic predisposition which is triggered by environmental risk factors.']	polygenic	SO_EXT	[12699]	[12708]	PMC1168874_T436
PMC1168874	PMC1168874_97	[12774]	[12921]	['The seemingly similar component CAs within multimalformed or syndromic cases are caused by chromosomal aberrations, gene mutations or teratogens28.']	chromosomal	GO_CC_EXT	[12865]	[12876]	PMC1168874_T366
PMC1168874	PMC1168874_97	[12774]	[12921]	['The seemingly similar component CAs within multimalformed or syndromic cases are caused by chromosomal aberrations, gene mutations or teratogens28.']	chromosomal	GO_CC_EXT	[12865]	[12876]	PMC1168874_T437
PMC1168874	PMC1168874_97	[12774]	[12921]	['The seemingly similar component CAs within multimalformed or syndromic cases are caused by chromosomal aberrations, gene mutations or teratogens28.']	gene	SO_EXT	[12890]	[12894]	PMC1168874_T438
PMC1168874	PMC1168874_97	[12774]	[12921]	['The seemingly similar component CAs within multimalformed or syndromic cases are caused by chromosomal aberrations, gene mutations or teratogens28.']	mutations	SO_EXT	[12895]	[12904]	PMC1168874_T439
PMC1168874	PMC1168874_99	[13041]	[13245]	['For example, isolated cleft lip has a left sided and male predominance while component cleft lip in syndromic cases has no side predominance and the sex ratio corresponds to the usual population figure29.']	lip	UBERON_EXT	[13069]	[13072]	PMC1168874_T484
PMC1168874	PMC1168874_99	[13041]	[13245]	['For example, isolated cleft lip has a left sided and male predominance while component cleft lip in syndromic cases has no side predominance and the sex ratio corresponds to the usual population figure29.']	male	UBERON_EXT	[13094]	[13098]	PMC1168874_T485
PMC1168874	PMC1168874_99	[13041]	[13245]	['For example, isolated cleft lip has a left sided and male predominance while component cleft lip in syndromic cases has no side predominance and the sex ratio corresponds to the usual population figure29.']	lip	UBERON_EXT	[13134]	[13137]	PMC1168874_T486
PMC1168874	PMC1168874_101	[13357]	[13687]	['The importance of different chemical structures, administrative routes and reasons for treatment at the teratogenic evaluation of medicinal products was not considered\nIn general, similar drugs were evaluated together such as penicillins, tetracyclines, cephalosporins (or sometimes as “antibiotics”) and sulfonamides in the past.']	chemical	CHEBI_EXT	[13385]	[13393]	PMC1168874_T125
PMC1168874	PMC1168874_101	[13357]	[13687]	['The importance of different chemical structures, administrative routes and reasons for treatment at the teratogenic evaluation of medicinal products was not considered\nIn general, similar drugs were evaluated together such as penicillins, tetracyclines, cephalosporins (or sometimes as “antibiotics”) and sulfonamides in the past.']	medicinal	CHEBI_EXT	[13487]	[13496]	PMC1168874_T126
PMC1168874	PMC1168874_101	[13357]	[13687]	['The importance of different chemical structures, administrative routes and reasons for treatment at the teratogenic evaluation of medicinal products was not considered\nIn general, similar drugs were evaluated together such as penicillins, tetracyclines, cephalosporins (or sometimes as “antibiotics”) and sulfonamides in the past.']	drugs	CHEBI_EXT	[13545]	[13550]	PMC1168874_T127
PMC1168874	PMC1168874_101	[13357]	[13687]	['The importance of different chemical structures, administrative routes and reasons for treatment at the teratogenic evaluation of medicinal products was not considered\nIn general, similar drugs were evaluated together such as penicillins, tetracyclines, cephalosporins (or sometimes as “antibiotics”) and sulfonamides in the past.']	penicillins	CHEBI_EXT	[13583]	[13594]	PMC1168874_T128
PMC1168874	PMC1168874_101	[13357]	[13687]	['The importance of different chemical structures, administrative routes and reasons for treatment at the teratogenic evaluation of medicinal products was not considered\nIn general, similar drugs were evaluated together such as penicillins, tetracyclines, cephalosporins (or sometimes as “antibiotics”) and sulfonamides in the past.']	tetracyclines	CHEBI_EXT	[13596]	[13609]	PMC1168874_T129
PMC1168874	PMC1168874_101	[13357]	[13687]	['The importance of different chemical structures, administrative routes and reasons for treatment at the teratogenic evaluation of medicinal products was not considered\nIn general, similar drugs were evaluated together such as penicillins, tetracyclines, cephalosporins (or sometimes as “antibiotics”) and sulfonamides in the past.']	cephalosporins	CHEBI_EXT	[13611]	[13625]	PMC1168874_T130
PMC1168874	PMC1168874_101	[13357]	[13687]	['The importance of different chemical structures, administrative routes and reasons for treatment at the teratogenic evaluation of medicinal products was not considered\nIn general, similar drugs were evaluated together such as penicillins, tetracyclines, cephalosporins (or sometimes as “antibiotics”) and sulfonamides in the past.']	antibiotics	CHEBI_EXT	[13644]	[13655]	PMC1168874_T131
PMC1168874	PMC1168874_101	[13357]	[13687]	['The importance of different chemical structures, administrative routes and reasons for treatment at the teratogenic evaluation of medicinal products was not considered\nIn general, similar drugs were evaluated together such as penicillins, tetracyclines, cephalosporins (or sometimes as “antibiotics”) and sulfonamides in the past.']	sulfonamides	CHEBI_EXT	[13662]	[13674]	PMC1168874_T132
PMC1168874	PMC1168874_102	[13688]	[13788]	['This approach is not correct because each drug within these groups has different chemical structure.']	drug	CHEBI_EXT	[13730]	[13734]	PMC1168874_T133
PMC1168874	PMC1168874_102	[13688]	[13788]	['This approach is not correct because each drug within these groups has different chemical structure.']	groups	CHEBI_EXT	[13748]	[13754]	PMC1168874_T134
PMC1168874	PMC1168874_102	[13688]	[13788]	['This approach is not correct because each drug within these groups has different chemical structure.']	chemical	CHEBI_EXT	[13769]	[13777]	PMC1168874_T135
PMC1168874	PMC1168874_103	[13789]	[13926]	['As we mentioned previously within the group of tetracyclines, oxytetracylines23were teratogenic while doxycyclines24were not teratogenic.']	tetracyclines	CHEBI_EXT	[13836]	[13849]	PMC1168874_T136
PMC1168874	PMC1168874_103	[13789]	[13926]	['As we mentioned previously within the group of tetracyclines, oxytetracylines23were teratogenic while doxycyclines24were not teratogenic.']	oxytetracylines23were	CHEBI_EXT	[13851]	[13872]	PMC1168874_T137
PMC1168874	PMC1168874_103	[13789]	[13926]	['As we mentioned previously within the group of tetracyclines, oxytetracylines23were teratogenic while doxycyclines24were not teratogenic.']	doxycyclines24were	CHEBI_EXT	[13891]	[13909]	PMC1168874_T138
PMC1168874	PMC1168874_104	[13927]	[14052]	['At the evaluation of seven orally used sulfonamides, only two showed teratogenic potential, and they induced different CAs30.']	sulfonamides	CHEBI_EXT	[13966]	[13978]	PMC1168874_T139
PMC1168874	PMC1168874_105	[14053]	[14121]	['Our studies showed the importance of interaction of different drugs.']	drugs	CHEBI_EXT	[14115]	[14120]	PMC1168874_T140
PMC1168874	PMC1168874_106	[14122]	[14305]	['We were not able to find a clinically important teratogenic effect after the use of oral metronidazole31and the topical miconazole treatment resulted in an obvious negative finding32.']	metronidazole31and	CHEBI_EXT	[14211]	[14229]	PMC1168874_T141
PMC1168874	PMC1168874_106	[14122]	[14305]	['We were not able to find a clinically important teratogenic effect after the use of oral metronidazole31and the topical miconazole treatment resulted in an obvious negative finding32.']	miconazole	CHEBI_EXT	[14242]	[14252]	PMC1168874_T142
PMC1168874	PMC1168874_107	[14306]	[14424]	['Nevertheless, the vaginal use of the combination of these two drugs increased the risk for poly/syndactyly six fold33.']	vaginal	UBERON_EXT	[14324]	[14331]	PMC1168874_T487
PMC1168874	PMC1168874_107	[14306]	[14424]	['Nevertheless, the vaginal use of the combination of these two drugs increased the risk for poly/syndactyly six fold33.']	drugs	CHEBI_EXT	[14368]	[14373]	PMC1168874_T143
PMC1168874	PMC1168874_108	[14425]	[14560]	['Our analyses also demonstrated that it is necessary to differentiate the administrative route of drugs and their teratogenic potential.']	drugs	CHEBI_EXT	[14522]	[14527]	PMC1168874_T144
PMC1168874	PMC1168874_109	[14561]	[14772]	['We should therefore evaluate the use of the same drugs (e.g., corticosteroids and antifungal agents) according to oral, parenteral, topical (skin, vaginal, eye and ear) and inhaled aerosol treatments separately.']	drugs	CHEBI_EXT	[14610]	[14615]	PMC1168874_T145
PMC1168874	PMC1168874_109	[14561]	[14772]	['We should therefore evaluate the use of the same drugs (e.g., corticosteroids and antifungal agents) according to oral, parenteral, topical (skin, vaginal, eye and ear) and inhaled aerosol treatments separately.']	corticosteroids	CHEBI_EXT	[14623]	[14638]	PMC1168874_T146
PMC1168874	PMC1168874_109	[14561]	[14772]	['We should therefore evaluate the use of the same drugs (e.g., corticosteroids and antifungal agents) according to oral, parenteral, topical (skin, vaginal, eye and ear) and inhaled aerosol treatments separately.']	antifungal agents	CHEBI_EXT	[14643]	[14660]	PMC1168874_T147
PMC1168874	PMC1168874_109	[14561]	[14772]	['We should therefore evaluate the use of the same drugs (e.g., corticosteroids and antifungal agents) according to oral, parenteral, topical (skin, vaginal, eye and ear) and inhaled aerosol treatments separately.']	skin	UBERON_EXT	[14702]	[14706]	PMC1168874_T488
PMC1168874	PMC1168874_109	[14561]	[14772]	['We should therefore evaluate the use of the same drugs (e.g., corticosteroids and antifungal agents) according to oral, parenteral, topical (skin, vaginal, eye and ear) and inhaled aerosol treatments separately.']	vaginal	UBERON_EXT	[14708]	[14715]	PMC1168874_T489
PMC1168874	PMC1168874_109	[14561]	[14772]	['We should therefore evaluate the use of the same drugs (e.g., corticosteroids and antifungal agents) according to oral, parenteral, topical (skin, vaginal, eye and ear) and inhaled aerosol treatments separately.']	eye	UBERON_EXT	[14717]	[14720]	PMC1168874_T490
PMC1168874	PMC1168874_109	[14561]	[14772]	['We should therefore evaluate the use of the same drugs (e.g., corticosteroids and antifungal agents) according to oral, parenteral, topical (skin, vaginal, eye and ear) and inhaled aerosol treatments separately.']	ear	UBERON_EXT	[14725]	[14728]	PMC1168874_T491
PMC1168874	PMC1168874_109	[14561]	[14772]	['We should therefore evaluate the use of the same drugs (e.g., corticosteroids and antifungal agents) according to oral, parenteral, topical (skin, vaginal, eye and ear) and inhaled aerosol treatments separately.']	aerosol	CHEBI_EXT	[14742]	[14749]	PMC1168874_T148
PMC1168874	PMC1168874_110	[14773]	[14872]	['Finally it is necessary to differentiate drugs and pregnancy supplements within medicinal products.']	drugs	CHEBI_EXT	[14814]	[14819]	PMC1168874_T149
PMC1168874	PMC1168874_110	[14773]	[14872]	['Finally it is necessary to differentiate drugs and pregnancy supplements within medicinal products.']	pregnancy	GO_BP_EXT	[14824]	[14833]	PMC1168874_T295
PMC1168874	PMC1168874_110	[14773]	[14872]	['Finally it is necessary to differentiate drugs and pregnancy supplements within medicinal products.']	medicinal	CHEBI_EXT	[14853]	[14862]	PMC1168874_T150
PMC1168874	PMC1168874_111	[14873]	[15170]	['Drugs are used for the treatment of maternal diseases and pregnancy complications during pregnancy while pregnancy supplements such as folic acid, other vitamins34, iron, calcium, multivitamins, etc are given to prevent pregnancy complications and unsuccessful pregnancy outcomes particularly CAs.']	Drugs	CHEBI_EXT	[14873]	[14878]	PMC1168874_T151
PMC1168874	PMC1168874_111	[14873]	[15170]	['Drugs are used for the treatment of maternal diseases and pregnancy complications during pregnancy while pregnancy supplements such as folic acid, other vitamins34, iron, calcium, multivitamins, etc are given to prevent pregnancy complications and unsuccessful pregnancy outcomes particularly CAs.']	pregnancy	GO_BP_EXT	[14931]	[14940]	PMC1168874_T296
PMC1168874	PMC1168874_111	[14873]	[15170]	['Drugs are used for the treatment of maternal diseases and pregnancy complications during pregnancy while pregnancy supplements such as folic acid, other vitamins34, iron, calcium, multivitamins, etc are given to prevent pregnancy complications and unsuccessful pregnancy outcomes particularly CAs.']	pregnancy	GO_BP_EXT	[14962]	[14971]	PMC1168874_T297
PMC1168874	PMC1168874_111	[14873]	[15170]	['Drugs are used for the treatment of maternal diseases and pregnancy complications during pregnancy while pregnancy supplements such as folic acid, other vitamins34, iron, calcium, multivitamins, etc are given to prevent pregnancy complications and unsuccessful pregnancy outcomes particularly CAs.']	pregnancy	GO_BP_EXT	[14978]	[14987]	PMC1168874_T298
PMC1168874	PMC1168874_111	[14873]	[15170]	['Drugs are used for the treatment of maternal diseases and pregnancy complications during pregnancy while pregnancy supplements such as folic acid, other vitamins34, iron, calcium, multivitamins, etc are given to prevent pregnancy complications and unsuccessful pregnancy outcomes particularly CAs.']	folic acid	CHEBI_EXT	[15008]	[15018]	PMC1168874_T152
PMC1168874	PMC1168874_111	[14873]	[15170]	['Drugs are used for the treatment of maternal diseases and pregnancy complications during pregnancy while pregnancy supplements such as folic acid, other vitamins34, iron, calcium, multivitamins, etc are given to prevent pregnancy complications and unsuccessful pregnancy outcomes particularly CAs.']	vitamins34	CHEBI_EXT	[15026]	[15036]	PMC1168874_T153
PMC1168874	PMC1168874_111	[14873]	[15170]	['Drugs are used for the treatment of maternal diseases and pregnancy complications during pregnancy while pregnancy supplements such as folic acid, other vitamins34, iron, calcium, multivitamins, etc are given to prevent pregnancy complications and unsuccessful pregnancy outcomes particularly CAs.']	iron	CHEBI_EXT	[15038]	[15042]	PMC1168874_T154
PMC1168874	PMC1168874_111	[14873]	[15170]	['Drugs are used for the treatment of maternal diseases and pregnancy complications during pregnancy while pregnancy supplements such as folic acid, other vitamins34, iron, calcium, multivitamins, etc are given to prevent pregnancy complications and unsuccessful pregnancy outcomes particularly CAs.']	calcium	CHEBI_EXT	[15044]	[15051]	PMC1168874_T155
PMC1168874	PMC1168874_111	[14873]	[15170]	['Drugs are used for the treatment of maternal diseases and pregnancy complications during pregnancy while pregnancy supplements such as folic acid, other vitamins34, iron, calcium, multivitamins, etc are given to prevent pregnancy complications and unsuccessful pregnancy outcomes particularly CAs.']	pregnancy	GO_BP_EXT	[15093]	[15102]	PMC1168874_T299
PMC1168874	PMC1168874_111	[14873]	[15170]	['Drugs are used for the treatment of maternal diseases and pregnancy complications during pregnancy while pregnancy supplements such as folic acid, other vitamins34, iron, calcium, multivitamins, etc are given to prevent pregnancy complications and unsuccessful pregnancy outcomes particularly CAs.']	pregnancy	GO_BP_EXT	[15134]	[15143]	PMC1168874_T300
PMC1168874	PMC1168874_112	[15171]	[15264]	['These opposite effects of medicinal products have to be considered when evaluating the drugs.']	medicinal products	CHEBI_EXT	[15197]	[15215]	PMC1168874_T156
PMC1168874	PMC1168874_112	[15171]	[15264]	['These opposite effects of medicinal products have to be considered when evaluating the drugs.']	drugs	CHEBI_EXT	[15258]	[15263]	PMC1168874_T157
PMC1168874	PMC1168874_114	[15270]	[15510]	['Recall bias\nThe birth of an infant with a CA is a serious traumatic event for most mothers, who therefore try to find a causal explanation such as drug use during pregnancy, something that does not occur after the birth of a healthy infant.']	birth of ... infant	GO_BP_EXT	[15286, 15298]	[15294, 15304]	PMC1168874_T301
PMC1168874	PMC1168874_114	[15270]	[15510]	['Recall bias\nThe birth of an infant with a CA is a serious traumatic event for most mothers, who therefore try to find a causal explanation such as drug use during pregnancy, something that does not occur after the birth of a healthy infant.']	infant	UBERON_EXT	[15298]	[15304]	PMC1168874_T492
PMC1168874	PMC1168874_114	[15270]	[15510]	['Recall bias\nThe birth of an infant with a CA is a serious traumatic event for most mothers, who therefore try to find a causal explanation such as drug use during pregnancy, something that does not occur after the birth of a healthy infant.']	pregnancy	GO_BP_EXT	[15433]	[15442]	PMC1168874_T302
PMC1168874	PMC1168874_114	[15270]	[15510]	['Recall bias\nThe birth of an infant with a CA is a serious traumatic event for most mothers, who therefore try to find a causal explanation such as drug use during pregnancy, something that does not occur after the birth of a healthy infant.']	birth	GO_BP_EXT	[15484]	[15489]	PMC1168874_T303
PMC1168874	PMC1168874_114	[15270]	[15510]	['Recall bias\nThe birth of an infant with a CA is a serious traumatic event for most mothers, who therefore try to find a causal explanation such as drug use during pregnancy, something that does not occur after the birth of a healthy infant.']	infant	UBERON_EXT	[15503]	[15509]	PMC1168874_T493
PMC1168874	PMC1168874_115	[15511]	[15714]	['Thus the mothers of babies affected with CAs are continually thinking of possible dangerous environmental factors and when asked about the history of their pregnancy, give a long list of supposed agents.']	pregnancy	GO_BP_EXT	[15667]	[15676]	PMC1168874_T304
PMC1168874	PMC1168874_115	[15511]	[15714]	['Thus the mothers of babies affected with CAs are continually thinking of possible dangerous environmental factors and when asked about the history of their pregnancy, give a long list of supposed agents.']	agents	CHEBI_EXT	[15707]	[15713]	PMC1168874_T158
PMC1168874	PMC1168874_116	[15715]	[15871]	['On the other hand the mothers of healthy babies are thinking of the present and future of their babies and are likely to forget events during the pregnancy.']	babies	UBERON_EXT	[15756]	[15762]	PMC1168874_T494
PMC1168874	PMC1168874_116	[15715]	[15871]	['On the other hand the mothers of healthy babies are thinking of the present and future of their babies and are likely to forget events during the pregnancy.']	thinking	GO_BP_EXT	[15767]	[15775]	PMC1168874_T305
PMC1168874	PMC1168874_116	[15715]	[15871]	['On the other hand the mothers of healthy babies are thinking of the present and future of their babies and are likely to forget events during the pregnancy.']	babies	UBERON_EXT	[15811]	[15817]	PMC1168874_T495
PMC1168874	PMC1168874_116	[15715]	[15871]	['On the other hand the mothers of healthy babies are thinking of the present and future of their babies and are likely to forget events during the pregnancy.']	pregnancy	GO_BP_EXT	[15861]	[15870]	PMC1168874_T306
PMC1168874	PMC1168874_117	[15872]	[16117]	['Retrospective (i.e., after the birth) maternal self-reported information therefore is different in the groups of case and control mothers and this recall bias can mimic an increased risk of drugs in the CA-groups up to an odds ratio of 1.9 (35).']	birth	GO_BP_EXT	[15903]	[15908]	PMC1168874_T307
PMC1168874	PMC1168874_117	[15872]	[16117]	['Retrospective (i.e., after the birth) maternal self-reported information therefore is different in the groups of case and control mothers and this recall bias can mimic an increased risk of drugs in the CA-groups up to an odds ratio of 1.9 (35).']	drugs	CHEBI_EXT	[16062]	[16067]	PMC1168874_T159
PMC1168874	PMC1168874_120	[16239]	[16401]	['Firstly, we evaluate 25 CA-groups and we expect a higher occurrence of one or some CA-groups after the use of the given drug due to the specificity of teratogens.']	drug	CHEBI_EXT	[16359]	[16363]	PMC1168874_T160
PMC1168874	PMC1168874_122	[16445]	[16596]	['Secondly, the use of the drug under study is evaluated during the critical period of CA formation, in general the second and third months of gestation.']	drug	CHEBI_EXT	[16470]	[16474]	PMC1168874_T161
PMC1168874	PMC1168874_122	[16445]	[16596]	['Secondly, the use of the drug under study is evaluated during the critical period of CA formation, in general the second and third months of gestation.']	gestation	GO_BP_EXT	[16586]	[16595]	PMC1168874_T308
PMC1168874	PMC1168874_123	[16597]	[16867]	['We may suppose that the teratogenic effect of the drug is shown only during this period because we expect an underreporting of exposure in both the critical and non-critical periods of CA formation in the mothers of healthy babies, i.e., in the population control group.']	drug	CHEBI_EXT	[16647]	[16651]	PMC1168874_T162
PMC1168874	PMC1168874_123	[16597]	[16867]	['We may suppose that the teratogenic effect of the drug is shown only during this period because we expect an underreporting of exposure in both the critical and non-critical periods of CA formation in the mothers of healthy babies, i.e., in the population control group.']	babies	UBERON_EXT	[16821]	[16827]	PMC1168874_T496
PMC1168874	PMC1168874_124	[16868]	[17025]	['Thirdly, an independent and prospective source of drug exposure data, e.g., the medically recorded data in the prenatal logbook may serve as a gold standard.']	drug	CHEBI_EXT	[16918]	[16922]	PMC1168874_T163
PMC1168874	PMC1168874_124	[16868]	[17025]	['Thirdly, an independent and prospective source of drug exposure data, e.g., the medically recorded data in the prenatal logbook may serve as a gold standard.']	prenatal	GO_BP_EXT	[16979]	[16987]	PMC1168874_T309
PMC1168874	PMC1168874_125	[17026]	[17243]	['Our validation study, however, showed that a small group of pregnant women (2.4%) did not use prescribed and medically recorded drugs or they shortened the duration of treatment due to the supposed teratogenic risk36.']	pregnant	GO_BP_EXT	[17086]	[17094]	PMC1168874_T310
PMC1168874	PMC1168874_125	[17026]	[17243]	['Our validation study, however, showed that a small group of pregnant women (2.4%) did not use prescribed and medically recorded drugs or they shortened the duration of treatment due to the supposed teratogenic risk36.']	women	NCBITAXON_EXT	[17095]	[17100]	PMC1168874_T402
PMC1168874	PMC1168874_125	[17026]	[17243]	['Our validation study, however, showed that a small group of pregnant women (2.4%) did not use prescribed and medically recorded drugs or they shortened the duration of treatment due to the supposed teratogenic risk36.']	women	UBERON_EXT	[17095]	[17100]	PMC1168874_T497
PMC1168874	PMC1168874_125	[17026]	[17243]	['Our validation study, however, showed that a small group of pregnant women (2.4%) did not use prescribed and medically recorded drugs or they shortened the duration of treatment due to the supposed teratogenic risk36.']	drugs	CHEBI_EXT	[17154]	[17159]	PMC1168874_T164
PMC1168874	PMC1168874_126	[17244]	[17339]	['Another independent and prospective source of drug exposure can be found in pharmacy records37.']	drug	CHEBI_EXT	[17290]	[17294]	PMC1168874_T165
PMC1168874	PMC1168874_128	[17435]	[17773]	['In our HCCSCA system, cases with Down syndrome are used as patient controls11because the cause of this numerical chromosomal aberration (trisomy 21) is not connected with the teratogenic effect of agents during pregnancy, and particularly in the critical period of most CA formation, i.e., during the second and third months of gestation.']	chromosomal	GO_CC_EXT	[17548]	[17559]	PMC1168874_T367
PMC1168874	PMC1168874_128	[17435]	[17773]	['In our HCCSCA system, cases with Down syndrome are used as patient controls11because the cause of this numerical chromosomal aberration (trisomy 21) is not connected with the teratogenic effect of agents during pregnancy, and particularly in the critical period of most CA formation, i.e., during the second and third months of gestation.']	chromosomal	GO_CC_EXT	[17548]	[17559]	PMC1168874_T440
PMC1168874	PMC1168874_128	[17435]	[17773]	['In our HCCSCA system, cases with Down syndrome are used as patient controls11because the cause of this numerical chromosomal aberration (trisomy 21) is not connected with the teratogenic effect of agents during pregnancy, and particularly in the critical period of most CA formation, i.e., during the second and third months of gestation.']	trisomy	SO_EXT	[17572]	[17579]	PMC1168874_T441
PMC1168874	PMC1168874_128	[17435]	[17773]	['In our HCCSCA system, cases with Down syndrome are used as patient controls11because the cause of this numerical chromosomal aberration (trisomy 21) is not connected with the teratogenic effect of agents during pregnancy, and particularly in the critical period of most CA formation, i.e., during the second and third months of gestation.']	pregnancy	GO_BP_EXT	[17646]	[17655]	PMC1168874_T311
PMC1168874	PMC1168874_128	[17435]	[17773]	['In our HCCSCA system, cases with Down syndrome are used as patient controls11because the cause of this numerical chromosomal aberration (trisomy 21) is not connected with the teratogenic effect of agents during pregnancy, and particularly in the critical period of most CA formation, i.e., during the second and third months of gestation.']	gestation	GO_BP_EXT	[17763]	[17772]	PMC1168874_T312
PMC1168874	PMC1168874_129	[17774]	[17955]	['Fifthly, “true” teratogens such as rubella virus, radiation, alcohol, hydantoin-phenytoin, warfarin-coumarin, accutane, etc., cause multiple CA with a characteristic pattern of CAs.']	rubella virus	NCBITAXON_EXT	[17809]	[17822]	PMC1168874_T403
PMC1168874	PMC1168874_129	[17774]	[17955]	['Fifthly, “true” teratogens such as rubella virus, radiation, alcohol, hydantoin-phenytoin, warfarin-coumarin, accutane, etc., cause multiple CA with a characteristic pattern of CAs.']	alcohol	CHEBI_EXT	[17835]	[17842]	PMC1168874_T166
PMC1168874	PMC1168874_129	[17774]	[17955]	['Fifthly, “true” teratogens such as rubella virus, radiation, alcohol, hydantoin-phenytoin, warfarin-coumarin, accutane, etc., cause multiple CA with a characteristic pattern of CAs.']	hydantoin	CHEBI_EXT	[17844]	[17853]	PMC1168874_T167
PMC1168874	PMC1168874_129	[17774]	[17955]	['Fifthly, “true” teratogens such as rubella virus, radiation, alcohol, hydantoin-phenytoin, warfarin-coumarin, accutane, etc., cause multiple CA with a characteristic pattern of CAs.']	phenytoin	CHEBI_EXT	[17854]	[17863]	PMC1168874_T168
PMC1168874	PMC1168874_129	[17774]	[17955]	['Fifthly, “true” teratogens such as rubella virus, radiation, alcohol, hydantoin-phenytoin, warfarin-coumarin, accutane, etc., cause multiple CA with a characteristic pattern of CAs.']	coumarin	CHEBI_EXT	[17874]	[17882]	PMC1168874_T169
PMC1168874	PMC1168874_129	[17774]	[17955]	['Fifthly, “true” teratogens such as rubella virus, radiation, alcohol, hydantoin-phenytoin, warfarin-coumarin, accutane, etc., cause multiple CA with a characteristic pattern of CAs.']	accutane	CHEBI_EXT	[17884]	[17892]	PMC1168874_T170
PMC1168874	PMC1168874_129	[17774]	[17955]	['Fifthly, “true” teratogens such as rubella virus, radiation, alcohol, hydantoin-phenytoin, warfarin-coumarin, accutane, etc., cause multiple CA with a characteristic pattern of CAs.']	CAs	GO_CC_EXT	[17951]	[17954]	PMC1168874_T368
PMC1168874	PMC1168874_131	[18073]	[18213]	['Another group of teratogens plays a role as trigger factors in the origin of isolated CAs based on polygenic-environmental interaction, i.e.']	teratogens	CHEBI_EXT	[18090]	[18100]	PMC1168874_T171
PMC1168874	PMC1168874_131	[18073]	[18213]	['Another group of teratogens plays a role as trigger factors in the origin of isolated CAs based on polygenic-environmental interaction, i.e.']	polygenic	SO_EXT	[18172]	[18181]	PMC1168874_T442
PMC1168874	PMC1168874_134	[18245]	[18286]	['Teratogenic risk of drugs is exaggerated.']	drugs	CHEBI_EXT	[18265]	[18270]	PMC1168874_T172
PMC1168874	PMC1168874_135	[18287]	[18363]	['The exaggeration of drug teratogenicity can be explained by several factors.']	drug	CHEBI_EXT	[18307]	[18311]	PMC1168874_T173
PMC1168874	PMC1168874_136	[18364]	[18476]	['At present the average number of children per family in Hungary is about 1.3 compared to 11 in the 19th century.']	children	NCBITAXON_EXT	[18397]	[18405]	PMC1168874_T404
PMC1168874	PMC1168874_136	[18364]	[18476]	['At present the average number of children per family in Hungary is about 1.3 compared to 11 in the 19th century.']	children	UBERON_EXT	[18397]	[18405]	PMC1168874_T498
PMC1168874	PMC1168874_137	[18477]	[18556]	['In the past, the social role of females was the “reproduction” of human beings.']	females	UBERON_EXT	[18509]	[18516]	PMC1168874_T499
PMC1168874	PMC1168874_137	[18477]	[18556]	['In the past, the social role of females was the “reproduction” of human beings.']	reproduction	GO_BP_EXT	[18526]	[18538]	PMC1168874_T313
PMC1168874	PMC1168874_137	[18477]	[18556]	['In the past, the social role of females was the “reproduction” of human beings.']	human beings	NCBITAXON_EXT	[18543]	[18555]	PMC1168874_T405
PMC1168874	PMC1168874_138	[18557]	[18712]	['Now they take part in the social “production” outside their homes similar to males but they have to fulfill their traditional role of reproduction as well.']	males	UBERON_EXT	[18634]	[18639]	PMC1168874_T500
PMC1168874	PMC1168874_138	[18557]	[18712]	['Now they take part in the social “production” outside their homes similar to males but they have to fulfill their traditional role of reproduction as well.']	reproduction	GO_BP_EXT	[18691]	[18703]	PMC1168874_T314
PMC1168874	PMC1168874_139	[18713]	[18818]	['A malformed or disabled child curtails their social activity hence the emphasis on having a healthy baby.']	child	NCBITAXON_EXT	[18737]	[18742]	PMC1168874_T406
PMC1168874	PMC1168874_139	[18713]	[18818]	['A malformed or disabled child curtails their social activity hence the emphasis on having a healthy baby.']	child	UBERON_EXT	[18737]	[18742]	PMC1168874_T501
PMC1168874	PMC1168874_139	[18713]	[18818]	['A malformed or disabled child curtails their social activity hence the emphasis on having a healthy baby.']	baby	UBERON_EXT	[18813]	[18817]	PMC1168874_T502
PMC1168874	PMC1168874_140	[18819]	[18961]	['The positive findings of animal investigations are frequently extrapolated for the human fetus contrary to the well-known species specificity.']	animal	NCBITAXON_EXT	[18844]	[18850]	PMC1168874_T407
PMC1168874	PMC1168874_140	[18819]	[18961]	['The positive findings of animal investigations are frequently extrapolated for the human fetus contrary to the well-known species specificity.']	human	NCBITAXON_EXT	[18902]	[18907]	PMC1168874_T408
PMC1168874	PMC1168874_140	[18819]	[18961]	['The positive findings of animal investigations are frequently extrapolated for the human fetus contrary to the well-known species specificity.']	species	NCBITAXON_EXT	[18941]	[18948]	PMC1168874_T409
PMC1168874	PMC1168874_142	[19123]	[19339]	['The editors of scientific periodicals have an aversion to publishing papers with negative results, but are happy to publish selected case reports and the positive findings of animal and human epidemiological studies.']	animal	NCBITAXON_EXT	[19298]	[19304]	PMC1168874_T410
PMC1168874	PMC1168874_142	[19123]	[19339]	['The editors of scientific periodicals have an aversion to publishing papers with negative results, but are happy to publish selected case reports and the positive findings of animal and human epidemiological studies.']	human	NCBITAXON_EXT	[19309]	[19314]	PMC1168874_T411
PMC1168874	PMC1168874_143	[19340]	[19429]	['This publication bias distorts the thinking of experts as well as the general population.']	thinking	GO_BP_EXT	[19375]	[19383]	PMC1168874_T315
PMC1168874	PMC1168874_144	[19430]	[19732]	['The false balance of risk and benefit of drug use during pregnancy is seriously augmented by the defensive policy of pharmaceutical companies and regulatory agencies which are gradually labeling most drugs with the recommendations to avoid their use during pregnancy, at least in “the first trimester”.']	drug	CHEBI_EXT	[19471]	[19475]	PMC1168874_T174
PMC1168874	PMC1168874_144	[19430]	[19732]	['The false balance of risk and benefit of drug use during pregnancy is seriously augmented by the defensive policy of pharmaceutical companies and regulatory agencies which are gradually labeling most drugs with the recommendations to avoid their use during pregnancy, at least in “the first trimester”.']	pregnancy	GO_BP_EXT	[19487]	[19496]	PMC1168874_T316
PMC1168874	PMC1168874_144	[19430]	[19732]	['The false balance of risk and benefit of drug use during pregnancy is seriously augmented by the defensive policy of pharmaceutical companies and regulatory agencies which are gradually labeling most drugs with the recommendations to avoid their use during pregnancy, at least in “the first trimester”.']	pharmaceutical	CHEBI_EXT	[19547]	[19561]	PMC1168874_T175
PMC1168874	PMC1168874_144	[19430]	[19732]	['The false balance of risk and benefit of drug use during pregnancy is seriously augmented by the defensive policy of pharmaceutical companies and regulatory agencies which are gradually labeling most drugs with the recommendations to avoid their use during pregnancy, at least in “the first trimester”.']	labeling	CHEBI_EXT	[19616]	[19624]	PMC1168874_T176
PMC1168874	PMC1168874_144	[19430]	[19732]	['The false balance of risk and benefit of drug use during pregnancy is seriously augmented by the defensive policy of pharmaceutical companies and regulatory agencies which are gradually labeling most drugs with the recommendations to avoid their use during pregnancy, at least in “the first trimester”.']	drugs	CHEBI_EXT	[19630]	[19635]	PMC1168874_T177
PMC1168874	PMC1168874_144	[19430]	[19732]	['The false balance of risk and benefit of drug use during pregnancy is seriously augmented by the defensive policy of pharmaceutical companies and regulatory agencies which are gradually labeling most drugs with the recommendations to avoid their use during pregnancy, at least in “the first trimester”.']	pregnancy	GO_BP_EXT	[19687]	[19696]	PMC1168874_T317
PMC1168874	PMC1168874_146	[19845]	[19946]	['They may not be well informed and may exaggerate the risk by relying on manufacturers drug pamphlets.']	drug	CHEBI_EXT	[19931]	[19935]	PMC1168874_T178
PMC1168874	PMC1168874_147	[19947]	[20132]	['They may also be thinking about possible law suits and are therefore over cautious forgetting that the chance of any pregnancy ending with a baby who has a major CA is approximately 3%.']	pregnancy	GO_BP_EXT	[20064]	[20073]	PMC1168874_T318
PMC1168874	PMC1168874_147	[19947]	[20132]	['They may also be thinking about possible law suits and are therefore over cautious forgetting that the chance of any pregnancy ending with a baby who has a major CA is approximately 3%.']	baby	UBERON_EXT	[20088]	[20092]	PMC1168874_T503
PMC1168874	PMC1168874_148	[20133]	[20215]	['The exaggeration of teratogenic risk of medicinal products causes several hazards.']	medicinal products	CHEBI_EXT	[20173]	[20191]	PMC1168874_T179
PMC1168874	PMC1168874_149	[20216]	[20361]	['First, many pregnant women do not get the necessary drug treatment and it results in serious consequences both for the mothers and their fetuses.']	pregnant	GO_BP_EXT	[20228]	[20236]	PMC1168874_T319
PMC1168874	PMC1168874_149	[20216]	[20361]	['First, many pregnant women do not get the necessary drug treatment and it results in serious consequences both for the mothers and their fetuses.']	women	NCBITAXON_EXT	[20237]	[20242]	PMC1168874_T412
PMC1168874	PMC1168874_149	[20216]	[20361]	['First, many pregnant women do not get the necessary drug treatment and it results in serious consequences both for the mothers and their fetuses.']	women	UBERON_EXT	[20237]	[20242]	PMC1168874_T504
PMC1168874	PMC1168874_149	[20216]	[20361]	['First, many pregnant women do not get the necessary drug treatment and it results in serious consequences both for the mothers and their fetuses.']	drug	CHEBI_EXT	[20268]	[20272]	PMC1168874_T180
PMC1168874	PMC1168874_150	[20362]	[20655]	['If influenza38and other acute infectious diseases of respiratory system39with high fever in early pregnancy are not treated by appropriate methods including drugs, therefore the teratogenic effect of hyperthermia can induce hyperthermic embryopathy (Table3), among others, neural-tube defects.']	influenza38and	NCBITAXON_EXT	[20365]	[20379]	PMC1168874_T413
PMC1168874	PMC1168874_150	[20362]	[20655]	['If influenza38and other acute infectious diseases of respiratory system39with high fever in early pregnancy are not treated by appropriate methods including drugs, therefore the teratogenic effect of hyperthermia can induce hyperthermic embryopathy (Table3), among others, neural-tube defects.']	respiratory system39with	UBERON_EXT	[20415]	[20439]	PMC1168874_T505
PMC1168874	PMC1168874_150	[20362]	[20655]	['If influenza38and other acute infectious diseases of respiratory system39with high fever in early pregnancy are not treated by appropriate methods including drugs, therefore the teratogenic effect of hyperthermia can induce hyperthermic embryopathy (Table3), among others, neural-tube defects.']	pregnancy	GO_BP_EXT	[20460]	[20469]	PMC1168874_T320
PMC1168874	PMC1168874_150	[20362]	[20655]	['If influenza38and other acute infectious diseases of respiratory system39with high fever in early pregnancy are not treated by appropriate methods including drugs, therefore the teratogenic effect of hyperthermia can induce hyperthermic embryopathy (Table3), among others, neural-tube defects.']	drugs	CHEBI_EXT	[20519]	[20524]	PMC1168874_T181
PMC1168874	PMC1168874_150	[20362]	[20655]	['If influenza38and other acute infectious diseases of respiratory system39with high fever in early pregnancy are not treated by appropriate methods including drugs, therefore the teratogenic effect of hyperthermia can induce hyperthermic embryopathy (Table3), among others, neural-tube defects.']	embryopathy	UBERON_EXT	[20599]	[20610]	PMC1168874_T506
PMC1168874	PMC1168874_150	[20362]	[20655]	['If influenza38and other acute infectious diseases of respiratory system39with high fever in early pregnancy are not treated by appropriate methods including drugs, therefore the teratogenic effect of hyperthermia can induce hyperthermic embryopathy (Table3), among others, neural-tube defects.']	neural-tube	UBERON_EXT	[20635]	[20646]	PMC1168874_T507
PMC1168874	PMC1168874_151	[20656]	[20781]	['In Hungary, about 40 % of pregnant women have some sexually transmitted infections and/or diseases in their genital organs40.']	pregnant	GO_BP_EXT	[20682]	[20690]	PMC1168874_T321
PMC1168874	PMC1168874_151	[20656]	[20781]	['In Hungary, about 40 % of pregnant women have some sexually transmitted infections and/or diseases in their genital organs40.']	women	NCBITAXON_EXT	[20691]	[20696]	PMC1168874_T414
PMC1168874	PMC1168874_151	[20656]	[20781]	['In Hungary, about 40 % of pregnant women have some sexually transmitted infections and/or diseases in their genital organs40.']	genital	UBERON_EXT	[20764]	[20771]	PMC1168874_T508
PMC1168874	PMC1168874_151	[20656]	[20781]	['In Hungary, about 40 % of pregnant women have some sexually transmitted infections and/or diseases in their genital organs40.']	organs40	UBERON_EXT	[20772]	[20780]	PMC1168874_T509
PMC1168874	PMC1168874_152	[20782]	[20943]	['Most medical doctors do not dare to treat them, therefore the ascending infections are followed by preterm birth and serious intrauterine infection of the fetus.']	birth	GO_BP_EXT	[20889]	[20894]	PMC1168874_T322
PMC1168874	PMC1168874_152	[20782]	[20943]	['Most medical doctors do not dare to treat them, therefore the ascending infections are followed by preterm birth and serious intrauterine infection of the fetus.']	intrauterine	UBERON_EXT	[20907]	[20919]	PMC1168874_T510
PMC1168874	PMC1168874_153	[20944]	[21092]	['Our study showed that the fetuses of inappropriately or untreated asthmatic pregnant women have a higher risk for intrauterine growth retardation41.']	fetuses	UBERON_EXT	[20970]	[20977]	PMC1168874_T511
PMC1168874	PMC1168874_153	[20944]	[21092]	['Our study showed that the fetuses of inappropriately or untreated asthmatic pregnant women have a higher risk for intrauterine growth retardation41.']	pregnant	GO_BP_EXT	[21020]	[21028]	PMC1168874_T323
PMC1168874	PMC1168874_153	[20944]	[21092]	['Our study showed that the fetuses of inappropriately or untreated asthmatic pregnant women have a higher risk for intrauterine growth retardation41.']	women	NCBITAXON_EXT	[21029]	[21034]	PMC1168874_T415
PMC1168874	PMC1168874_153	[20944]	[21092]	['Our study showed that the fetuses of inappropriately or untreated asthmatic pregnant women have a higher risk for intrauterine growth retardation41.']	women	UBERON_EXT	[21029]	[21034]	PMC1168874_T512
PMC1168874	PMC1168874_153	[20944]	[21092]	['Our study showed that the fetuses of inappropriately or untreated asthmatic pregnant women have a higher risk for intrauterine growth retardation41.']	intrauterine	UBERON_EXT	[21058]	[21070]	PMC1168874_T513
PMC1168874	PMC1168874_153	[20944]	[21092]	['Our study showed that the fetuses of inappropriately or untreated asthmatic pregnant women have a higher risk for intrauterine growth retardation41.']	growth	GO_BP_EXT	[21071]	[21077]	PMC1168874_T324
PMC1168874	PMC1168874_154	[21093]	[21236]	['Second, many planned and wanted pregnancies are terminated due to the anxiety and fear created by the notion that nearly all drugs cause CAs42.']	planned	GO_BP_EXT	[21106]	[21113]	PMC1168874_T325
PMC1168874	PMC1168874_154	[21093]	[21236]	['Second, many planned and wanted pregnancies are terminated due to the anxiety and fear created by the notion that nearly all drugs cause CAs42.']	pregnancies	GO_BP_EXT	[21125]	[21136]	PMC1168874_T326
PMC1168874	PMC1168874_154	[21093]	[21236]	['Second, many planned and wanted pregnancies are terminated due to the anxiety and fear created by the notion that nearly all drugs cause CAs42.']	drugs	CHEBI_EXT	[21218]	[21223]	PMC1168874_T182
PMC1168874	PMC1168874_155	[21237]	[21446]	['Recently the number of induced abortions before the 12th week of gestation is about 60,000 per year in Hungary and about 3,000 are terminated due to a medical indication connected to drug use during pregnancy.']	gestation	GO_BP_EXT	[21302]	[21311]	PMC1168874_T327
PMC1168874	PMC1168874_155	[21237]	[21446]	['Recently the number of induced abortions before the 12th week of gestation is about 60,000 per year in Hungary and about 3,000 are terminated due to a medical indication connected to drug use during pregnancy.']	drug	CHEBI_EXT	[21420]	[21424]	PMC1168874_T183
PMC1168874	PMC1168874_155	[21237]	[21446]	['Recently the number of induced abortions before the 12th week of gestation is about 60,000 per year in Hungary and about 3,000 are terminated due to a medical indication connected to drug use during pregnancy.']	pregnancy	GO_BP_EXT	[21436]	[21445]	PMC1168874_T328
PMC1168874	PMC1168874_156	[21447]	[21568]	['However, our analysis showed that the great majority of these pregnancy terminations had unfounded medical indications43.']	pregnancy	GO_BP_EXT	[21509]	[21518]	PMC1168874_T329
PMC1168874	PMC1168874_157	[21569]	[21729]	['Third, pregnant women using necessary drug treatments may suffer permanent psychological stress and may be seriously depressed until the end of the pregnancy44.']	pregnant	GO_BP_EXT	[21576]	[21584]	PMC1168874_T330
PMC1168874	PMC1168874_157	[21569]	[21729]	['Third, pregnant women using necessary drug treatments may suffer permanent psychological stress and may be seriously depressed until the end of the pregnancy44.']	women	NCBITAXON_EXT	[21585]	[21590]	PMC1168874_T416
PMC1168874	PMC1168874_157	[21569]	[21729]	['Third, pregnant women using necessary drug treatments may suffer permanent psychological stress and may be seriously depressed until the end of the pregnancy44.']	drug	CHEBI_EXT	[21607]	[21611]	PMC1168874_T184
PMC1168874	PMC1168874_157	[21569]	[21729]	['Third, pregnant women using necessary drug treatments may suffer permanent psychological stress and may be seriously depressed until the end of the pregnancy44.']	pregnancy44	GO_BP_EXT	[21717]	[21728]	PMC1168874_T331
PMC1168874	PMC1168874_158	[21730]	[21848]	['Fortunately the scientifically proved human teratogenic drugs are not used frequently in pregnant women (Table1and 2).']	human	NCBITAXON_EXT	[21768]	[21773]	PMC1168874_T417
PMC1168874	PMC1168874_158	[21730]	[21848]	['Fortunately the scientifically proved human teratogenic drugs are not used frequently in pregnant women (Table1and 2).']	teratogenic	CHEBI_EXT	[21774]	[21785]	PMC1168874_T185
PMC1168874	PMC1168874_158	[21730]	[21848]	['Fortunately the scientifically proved human teratogenic drugs are not used frequently in pregnant women (Table1and 2).']	drugs	CHEBI_EXT	[21786]	[21791]	PMC1168874_T186
PMC1168874	PMC1168874_158	[21730]	[21848]	['Fortunately the scientifically proved human teratogenic drugs are not used frequently in pregnant women (Table1and 2).']	pregnant	GO_BP_EXT	[21819]	[21827]	PMC1168874_T332
PMC1168874	PMC1168874_158	[21730]	[21848]	['Fortunately the scientifically proved human teratogenic drugs are not used frequently in pregnant women (Table1and 2).']	women	NCBITAXON_EXT	[21828]	[21833]	PMC1168874_T418
PMC1168874	PMC1168874_158	[21730]	[21848]	['Fortunately the scientifically proved human teratogenic drugs are not used frequently in pregnant women (Table1and 2).']	women	UBERON_EXT	[21828]	[21833]	PMC1168874_T514
PMC1168874	PMC1168874_159	[21849]	[22005]	['The total proportion of CAs induced by drugs is less than 1 % in the database of the HCCSCA, if we calculate 65.27 per 1,000 total rate of CAs in Hungary45.']	drugs	CHEBI_EXT	[21888]	[21893]	PMC1168874_T187
PMC1168874	PMC1168874_159	[21849]	[22005]	['The total proportion of CAs induced by drugs is less than 1 % in the database of the HCCSCA, if we calculate 65.27 per 1,000 total rate of CAs in Hungary45.']	CAs	GO_CC_EXT	[21988]	[21991]	PMC1168874_T369
PMC1168874	PMC1168874_161	[22010]	[22147]	['Benefit of medicine use during pregnancy is underestimated\nMaternal drug use during pregnancy may pose a teratogenic risk for the embryo.']	medicine	CHEBI_EXT	[22021]	[22029]	PMC1168874_T188
PMC1168874	PMC1168874_161	[22010]	[22147]	['Benefit of medicine use during pregnancy is underestimated\nMaternal drug use during pregnancy may pose a teratogenic risk for the embryo.']	pregnancy	GO_BP_EXT	[22041]	[22050]	PMC1168874_T333
PMC1168874	PMC1168874_161	[22010]	[22147]	['Benefit of medicine use during pregnancy is underestimated\nMaternal drug use during pregnancy may pose a teratogenic risk for the embryo.']	drug	CHEBI_EXT	[22078]	[22082]	PMC1168874_T189
PMC1168874	PMC1168874_161	[22010]	[22147]	['Benefit of medicine use during pregnancy is underestimated\nMaternal drug use during pregnancy may pose a teratogenic risk for the embryo.']	pregnancy	GO_BP_EXT	[22094]	[22103]	PMC1168874_T334
PMC1168874	PMC1168874_161	[22010]	[22147]	['Benefit of medicine use during pregnancy is underestimated\nMaternal drug use during pregnancy may pose a teratogenic risk for the embryo.']	teratogenic	GO_BP_EXT	[22115]	[22126]	PMC1168874_T335
PMC1168874	PMC1168874_161	[22010]	[22147]	['Benefit of medicine use during pregnancy is underestimated\nMaternal drug use during pregnancy may pose a teratogenic risk for the embryo.']	embryo	UBERON_EXT	[22140]	[22146]	PMC1168874_T515
PMC1168874	PMC1168874_162	[22148]	[22255]	['However, the recommendation to avoid all drugs during early pregnancy42is unrealistic and may be dangerous.']	drugs	CHEBI_EXT	[22189]	[22194]	PMC1168874_T190
PMC1168874	PMC1168874_162	[22148]	[22255]	['However, the recommendation to avoid all drugs during early pregnancy42is unrealistic and may be dangerous.']	pregnancy42is	GO_BP_EXT	[22208]	[22221]	PMC1168874_T336
PMC1168874	PMC1168874_163	[22256]	[22465]	['About 8% of pregnant women need permanent drug treatment due to their chronic diseases such as epilepsy, diabetes mellitus, bronchial asthma, hypertension, thyroid disorders, migraine, and severe depression40.']	pregnant	GO_BP_EXT	[22268]	[22276]	PMC1168874_T337
PMC1168874	PMC1168874_163	[22256]	[22465]	['About 8% of pregnant women need permanent drug treatment due to their chronic diseases such as epilepsy, diabetes mellitus, bronchial asthma, hypertension, thyroid disorders, migraine, and severe depression40.']	women	NCBITAXON_EXT	[22277]	[22282]	PMC1168874_T419
PMC1168874	PMC1168874_163	[22256]	[22465]	['About 8% of pregnant women need permanent drug treatment due to their chronic diseases such as epilepsy, diabetes mellitus, bronchial asthma, hypertension, thyroid disorders, migraine, and severe depression40.']	women	UBERON_EXT	[22277]	[22282]	PMC1168874_T516
PMC1168874	PMC1168874_163	[22256]	[22465]	['About 8% of pregnant women need permanent drug treatment due to their chronic diseases such as epilepsy, diabetes mellitus, bronchial asthma, hypertension, thyroid disorders, migraine, and severe depression40.']	drug	CHEBI_EXT	[22298]	[22302]	PMC1168874_T191
PMC1168874	PMC1168874_163	[22256]	[22465]	['About 8% of pregnant women need permanent drug treatment due to their chronic diseases such as epilepsy, diabetes mellitus, bronchial asthma, hypertension, thyroid disorders, migraine, and severe depression40.']	bronchial	UBERON_EXT	[22380]	[22389]	PMC1168874_T517
PMC1168874	PMC1168874_163	[22256]	[22465]	['About 8% of pregnant women need permanent drug treatment due to their chronic diseases such as epilepsy, diabetes mellitus, bronchial asthma, hypertension, thyroid disorders, migraine, and severe depression40.']	thyroid	UBERON_EXT	[22412]	[22419]	PMC1168874_T518
PMC1168874	PMC1168874_164	[22466]	[22669]	['More pregnant women require transient drug treatment because of influenza, acute infectious diseases of respiratory system and urogenital organs, the latter mainly due to sexually transmitted infections.']	pregnant	GO_BP_EXT	[22471]	[22479]	PMC1168874_T338
PMC1168874	PMC1168874_164	[22466]	[22669]	['More pregnant women require transient drug treatment because of influenza, acute infectious diseases of respiratory system and urogenital organs, the latter mainly due to sexually transmitted infections.']	women	NCBITAXON_EXT	[22480]	[22485]	PMC1168874_T420
PMC1168874	PMC1168874_164	[22466]	[22669]	['More pregnant women require transient drug treatment because of influenza, acute infectious diseases of respiratory system and urogenital organs, the latter mainly due to sexually transmitted infections.']	women	UBERON_EXT	[22480]	[22485]	PMC1168874_T519
PMC1168874	PMC1168874_164	[22466]	[22669]	['More pregnant women require transient drug treatment because of influenza, acute infectious diseases of respiratory system and urogenital organs, the latter mainly due to sexually transmitted infections.']	drug	CHEBI_EXT	[22504]	[22508]	PMC1168874_T192
PMC1168874	PMC1168874_164	[22466]	[22669]	['More pregnant women require transient drug treatment because of influenza, acute infectious diseases of respiratory system and urogenital organs, the latter mainly due to sexually transmitted infections.']	influenza	NCBITAXON_EXT	[22530]	[22539]	PMC1168874_T421
PMC1168874	PMC1168874_164	[22466]	[22669]	['More pregnant women require transient drug treatment because of influenza, acute infectious diseases of respiratory system and urogenital organs, the latter mainly due to sexually transmitted infections.']	respiratory system	UBERON_EXT	[22570]	[22588]	PMC1168874_T520
PMC1168874	PMC1168874_164	[22466]	[22669]	['More pregnant women require transient drug treatment because of influenza, acute infectious diseases of respiratory system and urogenital organs, the latter mainly due to sexually transmitted infections.']	urogenital organs	UBERON_EXT	[22593]	[22610]	PMC1168874_T521
PMC1168874	PMC1168874_165	[22670]	[22777]	['In addition, headache, nervousness, constipation and other common complaints may also need drug treatments.']	nervousness	UBERON_EXT	[22693]	[22704]	PMC1168874_T522
PMC1168874	PMC1168874_165	[22670]	[22777]	['In addition, headache, nervousness, constipation and other common complaints may also need drug treatments.']	drug	CHEBI_EXT	[22761]	[22765]	PMC1168874_T193
PMC1168874	PMC1168874_166	[22778]	[22951]	['Finally there are many pregnancy complications such as nausea and vomiting, threatened abortion, preterm delivery, toxemia and anemia which may also require drug treatments.']	pregnancy	GO_BP_EXT	[22801]	[22810]	PMC1168874_T339
PMC1168874	PMC1168874_166	[22778]	[22951]	['Finally there are many pregnancy complications such as nausea and vomiting, threatened abortion, preterm delivery, toxemia and anemia which may also require drug treatments.']	delivery	GO_BP_EXT	[22883]	[22891]	PMC1168874_T340
PMC1168874	PMC1168874_166	[22778]	[22951]	['Finally there are many pregnancy complications such as nausea and vomiting, threatened abortion, preterm delivery, toxemia and anemia which may also require drug treatments.']	drug	CHEBI_EXT	[22935]	[22939]	PMC1168874_T194
PMC1168874	PMC1168874_167	[22952]	[23196]	['The benefits of medicine use during pregnancy are not restricted to the recovery of maternal health but also result in some advantages for the fetus as well, because the maternal well-being is important for the optimal development of the fetus.']	medicine	CHEBI_EXT	[22968]	[22976]	PMC1168874_T195
PMC1168874	PMC1168874_167	[22952]	[23196]	['The benefits of medicine use during pregnancy are not restricted to the recovery of maternal health but also result in some advantages for the fetus as well, because the maternal well-being is important for the optimal development of the fetus.']	pregnancy	GO_BP_EXT	[22988]	[22997]	PMC1168874_T341
PMC1168874	PMC1168874_167	[22952]	[23196]	['The benefits of medicine use during pregnancy are not restricted to the recovery of maternal health but also result in some advantages for the fetus as well, because the maternal well-being is important for the optimal development of the fetus.']	maternal well-being	GO_BP_EXT	[23122]	[23141]	PMC1168874_T342
PMC1168874	PMC1168874_167	[22952]	[23196]	['The benefits of medicine use during pregnancy are not restricted to the recovery of maternal health but also result in some advantages for the fetus as well, because the maternal well-being is important for the optimal development of the fetus.']	development of ... fetus	GO_BP_EXT	[23171, 23190]	[23185, 23195]	PMC1168874_T343
PMC1168874	PMC1168874_169	[23270]	[23368]	['However, the appropriate management of diabetic pregnant women can prevent diabetic embryopathy46.']	pregnant	GO_BP_EXT	[23318]	[23326]	PMC1168874_T344
PMC1168874	PMC1168874_169	[23270]	[23368]	['However, the appropriate management of diabetic pregnant women can prevent diabetic embryopathy46.']	women	NCBITAXON_EXT	[23327]	[23332]	PMC1168874_T422
PMC1168874	PMC1168874_169	[23270]	[23368]	['However, the appropriate management of diabetic pregnant women can prevent diabetic embryopathy46.']	women	UBERON_EXT	[23327]	[23332]	PMC1168874_T523
PMC1168874	PMC1168874_170	[23369]	[23563]	['In addition the effective treatment of infectious diseases of genital organs can significantly reduce the prevalence of preterm birth and its related effects, among others, undescended testis47.']	genital	UBERON_EXT	[23431]	[23438]	PMC1168874_T524
PMC1168874	PMC1168874_170	[23369]	[23563]	['In addition the effective treatment of infectious diseases of genital organs can significantly reduce the prevalence of preterm birth and its related effects, among others, undescended testis47.']	organs	UBERON_EXT	[23439]	[23445]	PMC1168874_T525
PMC1168874	PMC1168874_170	[23369]	[23563]	['In addition the effective treatment of infectious diseases of genital organs can significantly reduce the prevalence of preterm birth and its related effects, among others, undescended testis47.']	birth	GO_BP_EXT	[23497]	[23502]	PMC1168874_T345
PMC1168874	PMC1168874_170	[23369]	[23563]	['In addition the effective treatment of infectious diseases of genital organs can significantly reduce the prevalence of preterm birth and its related effects, among others, undescended testis47.']	testis47	UBERON_EXT	[23554]	[23562]	PMC1168874_T526
PMC1168874	PMC1168874_171	[23564]	[23800]	['Finally the periconceptional folic acid or folic acid-containing multivitamin supplementation can prevent most neural-tube defects48and a considerable number of CAs in the cardiovascular system, urinary tract and limb deficiencies49-51.']	folic acid	CHEBI_EXT	[23593]	[23603]	PMC1168874_T196
PMC1168874	PMC1168874_171	[23564]	[23800]	['Finally the periconceptional folic acid or folic acid-containing multivitamin supplementation can prevent most neural-tube defects48and a considerable number of CAs in the cardiovascular system, urinary tract and limb deficiencies49-51.']	folic acid	CHEBI_EXT	[23607]	[23617]	PMC1168874_T197
PMC1168874	PMC1168874_171	[23564]	[23800]	['Finally the periconceptional folic acid or folic acid-containing multivitamin supplementation can prevent most neural-tube defects48and a considerable number of CAs in the cardiovascular system, urinary tract and limb deficiencies49-51.']	neural-tube	UBERON_EXT	[23675]	[23686]	PMC1168874_T527
PMC1168874	PMC1168874_171	[23564]	[23800]	['Finally the periconceptional folic acid or folic acid-containing multivitamin supplementation can prevent most neural-tube defects48and a considerable number of CAs in the cardiovascular system, urinary tract and limb deficiencies49-51.']	cardiovascular system	UBERON_EXT	[23736]	[23757]	PMC1168874_T528
PMC1168874	PMC1168874_171	[23564]	[23800]	['Finally the periconceptional folic acid or folic acid-containing multivitamin supplementation can prevent most neural-tube defects48and a considerable number of CAs in the cardiovascular system, urinary tract and limb deficiencies49-51.']	urinary	UBERON_EXT	[23759]	[23766]	PMC1168874_T529
PMC1168874	PMC1168874_171	[23564]	[23800]	['Finally the periconceptional folic acid or folic acid-containing multivitamin supplementation can prevent most neural-tube defects48and a considerable number of CAs in the cardiovascular system, urinary tract and limb deficiencies49-51.']	tract	UBERON_EXT	[23767]	[23772]	PMC1168874_T530
PMC1168874	PMC1168874_171	[23564]	[23800]	['Finally the periconceptional folic acid or folic acid-containing multivitamin supplementation can prevent most neural-tube defects48and a considerable number of CAs in the cardiovascular system, urinary tract and limb deficiencies49-51.']	limb	UBERON_EXT	[23777]	[23781]	PMC1168874_T531
PMC1168874	PMC1168874_172	[23801]	[23892]	['Previously we mentioned that less than 1 % of CAs may be caused by human teratogenic drugs.']	human	NCBITAXON_EXT	[23868]	[23873]	PMC1168874_T423
PMC1168874	PMC1168874_172	[23801]	[23892]	['Previously we mentioned that less than 1 % of CAs may be caused by human teratogenic drugs.']	teratogenic	CHEBI_EXT	[23874]	[23885]	PMC1168874_T198
PMC1168874	PMC1168874_172	[23801]	[23892]	['Previously we mentioned that less than 1 % of CAs may be caused by human teratogenic drugs.']	drugs	CHEBI_EXT	[23886]	[23891]	PMC1168874_T199
PMC1168874	PMC1168874_173	[23893]	[24004]	['The number of CAs induced by human teratogenic drugs is about 6 per 1,000 on the basis of Table1and 2 (Table3).']	human	NCBITAXON_EXT	[23922]	[23927]	PMC1168874_T424
PMC1168874	PMC1168874_173	[23893]	[24004]	['The number of CAs induced by human teratogenic drugs is about 6 per 1,000 on the basis of Table1and 2 (Table3).']	teratogenic	CHEBI_EXT	[23928]	[23939]	PMC1168874_T200
PMC1168874	PMC1168874_173	[23893]	[24004]	['The number of CAs induced by human teratogenic drugs is about 6 per 1,000 on the basis of Table1and 2 (Table3).']	drugs	CHEBI_EXT	[23940]	[23945]	PMC1168874_T201
PMC1168874	PMC1168874_175	[24059]	[24142]	['However, there is another aspect of CA prevention which is connected with drug use.']	drug	CHEBI_EXT	[24133]	[24137]	PMC1168874_T202
PMC1168874	PMC1168874_176	[24143]	[24318]	['High fever (at least 38.9ºC) due to influenza38and acute respiratory diseases39during the second and third months of gestation occurs in about 4% of pregnant women in Hungary.']	respiratory	UBERON_EXT	[24200]	[24211]	PMC1168874_T532
PMC1168874	PMC1168874_176	[24143]	[24318]	['High fever (at least 38.9ºC) due to influenza38and acute respiratory diseases39during the second and third months of gestation occurs in about 4% of pregnant women in Hungary.']	gestation	GO_BP_EXT	[24260]	[24269]	PMC1168874_T346
PMC1168874	PMC1168874_176	[24143]	[24318]	['High fever (at least 38.9ºC) due to influenza38and acute respiratory diseases39during the second and third months of gestation occurs in about 4% of pregnant women in Hungary.']	pregnant	GO_BP_EXT	[24292]	[24300]	PMC1168874_T347
PMC1168874	PMC1168874_177	[24319]	[24479]	['Offspring of these pregnant women have a higher risk for neural-tube defects, cleft lip with or without cleft palate, posterior cleft palate and some other CAs.']	pregnant	GO_BP_EXT	[24338]	[24346]	PMC1168874_T348
PMC1168874	PMC1168874_177	[24319]	[24479]	['Offspring of these pregnant women have a higher risk for neural-tube defects, cleft lip with or without cleft palate, posterior cleft palate and some other CAs.']	women	NCBITAXON_EXT	[24347]	[24352]	PMC1168874_T425
PMC1168874	PMC1168874_177	[24319]	[24479]	['Offspring of these pregnant women have a higher risk for neural-tube defects, cleft lip with or without cleft palate, posterior cleft palate and some other CAs.']	neural-tube	UBERON_EXT	[24376]	[24387]	PMC1168874_T533
PMC1168874	PMC1168874_177	[24319]	[24479]	['Offspring of these pregnant women have a higher risk for neural-tube defects, cleft lip with or without cleft palate, posterior cleft palate and some other CAs.']	lip	UBERON_EXT	[24403]	[24406]	PMC1168874_T534
PMC1168874	PMC1168874_178	[24480]	[24651]	['The total number of CAs which may be associated with hyperthermia is 8.7 per 1,000 and these CAs can be prevented by effective antifever therapy, including drugs (Table3).']	drugs	CHEBI_EXT	[24636]	[24641]	PMC1168874_T203
PMC1168874	PMC1168874_179	[24652]	[24789]	['Thus our estimation shows that CA-preventive effect of only antifever drugs may exceed the CA risk caused by all human teratogenic drugs.']	drugs	CHEBI_EXT	[24722]	[24727]	PMC1168874_T204
PMC1168874	PMC1168874_179	[24652]	[24789]	['Thus our estimation shows that CA-preventive effect of only antifever drugs may exceed the CA risk caused by all human teratogenic drugs.']	human	NCBITAXON_EXT	[24765]	[24770]	PMC1168874_T426
PMC1168874	PMC1168874_179	[24652]	[24789]	['Thus our estimation shows that CA-preventive effect of only antifever drugs may exceed the CA risk caused by all human teratogenic drugs.']	teratogenic	CHEBI_EXT	[24771]	[24782]	PMC1168874_T205
PMC1168874	PMC1168874_179	[24652]	[24789]	['Thus our estimation shows that CA-preventive effect of only antifever drugs may exceed the CA risk caused by all human teratogenic drugs.']	drugs	CHEBI_EXT	[24783]	[24788]	PMC1168874_T206
PMC1168874	PMC1168874_180	[24790]	[24888]	['Thus, a better balance is needed between the risk and benefit of drug treatments during pregnancy.']	drug	CHEBI_EXT	[24855]	[24859]	PMC1168874_T207
PMC1168874	PMC1168874_180	[24790]	[24888]	['Thus, a better balance is needed between the risk and benefit of drug treatments during pregnancy.']	pregnancy	GO_BP_EXT	[24878]	[24887]	PMC1168874_T349
PMC1168874	PMC1168874_182	[24893]	[25051]	['General conclusions\nThe use of teratogenic drugs should be avoided during pregnancy in less severe (non life-threatening) diseases such as acne and psoriasis.']	teratogenic	CHEBI_EXT	[24924]	[24935]	PMC1168874_T208
PMC1168874	PMC1168874_182	[24893]	[25051]	['General conclusions\nThe use of teratogenic drugs should be avoided during pregnancy in less severe (non life-threatening) diseases such as acne and psoriasis.']	teratogenic	GO_BP_EXT	[24924]	[24935]	PMC1168874_T350
PMC1168874	PMC1168874_182	[24893]	[25051]	['General conclusions\nThe use of teratogenic drugs should be avoided during pregnancy in less severe (non life-threatening) diseases such as acne and psoriasis.']	drugs	CHEBI_EXT	[24936]	[24941]	PMC1168874_T209
PMC1168874	PMC1168874_182	[24893]	[25051]	['General conclusions\nThe use of teratogenic drugs should be avoided during pregnancy in less severe (non life-threatening) diseases such as acne and psoriasis.']	pregnancy	GO_BP_EXT	[24967]	[24976]	PMC1168874_T351
PMC1168874	PMC1168874_183	[25052]	[25193]	['It is necessary to select non-teratogenic drugs instead of teratogenic drugs during pregnancy if possible and not harmful for pregnant women.']	teratogenic	CHEBI_EXT	[25082]	[25093]	PMC1168874_T210
PMC1168874	PMC1168874_183	[25052]	[25193]	['It is necessary to select non-teratogenic drugs instead of teratogenic drugs during pregnancy if possible and not harmful for pregnant women.']	drugs	CHEBI_EXT	[25094]	[25099]	PMC1168874_T211
PMC1168874	PMC1168874_183	[25052]	[25193]	['It is necessary to select non-teratogenic drugs instead of teratogenic drugs during pregnancy if possible and not harmful for pregnant women.']	teratogenic	CHEBI_EXT	[25111]	[25122]	PMC1168874_T212
PMC1168874	PMC1168874_183	[25052]	[25193]	['It is necessary to select non-teratogenic drugs instead of teratogenic drugs during pregnancy if possible and not harmful for pregnant women.']	drugs	CHEBI_EXT	[25123]	[25128]	PMC1168874_T213
PMC1168874	PMC1168874_183	[25052]	[25193]	['It is necessary to select non-teratogenic drugs instead of teratogenic drugs during pregnancy if possible and not harmful for pregnant women.']	pregnancy	GO_BP_EXT	[25136]	[25145]	PMC1168874_T352
PMC1168874	PMC1168874_183	[25052]	[25193]	['It is necessary to select non-teratogenic drugs instead of teratogenic drugs during pregnancy if possible and not harmful for pregnant women.']	pregnant	GO_BP_EXT	[25178]	[25186]	PMC1168874_T353
PMC1168874	PMC1168874_183	[25052]	[25193]	['It is necessary to select non-teratogenic drugs instead of teratogenic drugs during pregnancy if possible and not harmful for pregnant women.']	women	NCBITAXON_EXT	[25187]	[25192]	PMC1168874_T427
PMC1168874	PMC1168874_184	[25194]	[25295]	['The best example for this strategy is to replace coumarin derivative with heparin in early pregnancy.']	coumarin	CHEBI_EXT	[25243]	[25251]	PMC1168874_T214
PMC1168874	PMC1168874_184	[25194]	[25295]	['The best example for this strategy is to replace coumarin derivative with heparin in early pregnancy.']	heparin	CHEBI_EXT	[25268]	[25275]	PMC1168874_T215
PMC1168874	PMC1168874_184	[25194]	[25295]	['The best example for this strategy is to replace coumarin derivative with heparin in early pregnancy.']	pregnancy	GO_BP_EXT	[25285]	[25294]	PMC1168874_T354
PMC1168874	PMC1168874_185	[25296]	[25517]	['The necessary use of teratogenic drugs may have to be continued in severe maternal diseases such as epilepsy and cancer if the discontinuation of treatment causes worsening of the disease and pregnant women agree with it.']	teratogenic	CHEBI_EXT	[25317]	[25328]	PMC1168874_T216
PMC1168874	PMC1168874_185	[25296]	[25517]	['The necessary use of teratogenic drugs may have to be continued in severe maternal diseases such as epilepsy and cancer if the discontinuation of treatment causes worsening of the disease and pregnant women agree with it.']	drugs	CHEBI_EXT	[25329]	[25334]	PMC1168874_T217
PMC1168874	PMC1168874_185	[25296]	[25517]	['The necessary use of teratogenic drugs may have to be continued in severe maternal diseases such as epilepsy and cancer if the discontinuation of treatment causes worsening of the disease and pregnant women agree with it.']	pregnant	GO_BP_EXT	[25488]	[25496]	PMC1168874_T355
PMC1168874	PMC1168874_185	[25296]	[25517]	['The necessary use of teratogenic drugs may have to be continued in severe maternal diseases such as epilepsy and cancer if the discontinuation of treatment causes worsening of the disease and pregnant women agree with it.']	women	NCBITAXON_EXT	[25497]	[25502]	PMC1168874_T428
PMC1168874	PMC1168874_186	[25518]	[25654]	['Teratogenic drugs cannot cause CAs if the exposure is in the first month of gestation and in general after the third month of pregnancy.']	Teratogenic	CHEBI_EXT	[25518]	[25529]	PMC1168874_T218
PMC1168874	PMC1168874_186	[25518]	[25654]	['Teratogenic drugs cannot cause CAs if the exposure is in the first month of gestation and in general after the third month of pregnancy.']	drugs	CHEBI_EXT	[25530]	[25535]	PMC1168874_T219
PMC1168874	PMC1168874_186	[25518]	[25654]	['Teratogenic drugs cannot cause CAs if the exposure is in the first month of gestation and in general after the third month of pregnancy.']	gestation	GO_BP_EXT	[25594]	[25603]	PMC1168874_T356
PMC1168874	PMC1168874_186	[25518]	[25654]	['Teratogenic drugs cannot cause CAs if the exposure is in the first month of gestation and in general after the third month of pregnancy.']	pregnancy	GO_BP_EXT	[25644]	[25653]	PMC1168874_T357
PMC1168874	PMC1168874_187	[25655]	[25752]	['However, the fetotoxic effect of some drugs should be considered in the second part of pregnancy.']	drugs	CHEBI_EXT	[25693]	[25698]	PMC1168874_T220
PMC1168874	PMC1168874_187	[25655]	[25752]	['However, the fetotoxic effect of some drugs should be considered in the second part of pregnancy.']	pregnancy	GO_BP_EXT	[25742]	[25751]	PMC1168874_T358
PMC1168874	PMC1168874_188	[25753]	[25890]	['Recent effective ultrasound scanning can detect major fetal defects about the 18th-20th week of gestation with a high degree of efficacy.']	gestation	GO_BP_EXT	[25849]	[25858]	PMC1168874_T359
PMC1168874	PMC1168874_189	[25891]	[26011]	['Thus we have a chance to evaluate the risk after the inadvertent or necessary use of teratogenic drugs during pregnancy.']	teratogenic	CHEBI_EXT	[25976]	[25987]	PMC1168874_T221
PMC1168874	PMC1168874_189	[25891]	[26011]	['Thus we have a chance to evaluate the risk after the inadvertent or necessary use of teratogenic drugs during pregnancy.']	teratogenic	GO_BP_EXT	[25976]	[25987]	PMC1168874_T360
PMC1168874	PMC1168874_189	[25891]	[26011]	['Thus we have a chance to evaluate the risk after the inadvertent or necessary use of teratogenic drugs during pregnancy.']	drugs	CHEBI_EXT	[25988]	[25993]	PMC1168874_T222
PMC1168874	PMC1168874_189	[25891]	[26011]	['Thus we have a chance to evaluate the risk after the inadvertent or necessary use of teratogenic drugs during pregnancy.']	pregnancy	GO_BP_EXT	[26001]	[26010]	PMC1168874_T361
PMC1168874	PMC1168874_190	[26012]	[26156]	['If serious fetal defects are detected, the couple can then be given information to help them decide whether to terminate their pregnancy or not.']	pregnancy	GO_BP_EXT	[26139]	[26148]	PMC1168874_T362
PMC1168874	PMC1168874_191	[26157]	[26427]	['The use of non-teratogenic drugs may prevent the teratogenic effect of maternal diseases such as diabetes mellitus, influenza, and other acute infectious diseases with high fever and this preventable part of CAs exceeds the proportion of CAs caused by teratogenic drugs.']	drugs	CHEBI_EXT	[26184]	[26189]	PMC1168874_T223
PMC1168874	PMC1168874_191	[26157]	[26427]	['The use of non-teratogenic drugs may prevent the teratogenic effect of maternal diseases such as diabetes mellitus, influenza, and other acute infectious diseases with high fever and this preventable part of CAs exceeds the proportion of CAs caused by teratogenic drugs.']	influenza	NCBITAXON_EXT	[26273]	[26282]	PMC1168874_T429
PMC1168874	PMC1168874_191	[26157]	[26427]	['The use of non-teratogenic drugs may prevent the teratogenic effect of maternal diseases such as diabetes mellitus, influenza, and other acute infectious diseases with high fever and this preventable part of CAs exceeds the proportion of CAs caused by teratogenic drugs.']	teratogenic	CHEBI_EXT	[26409]	[26420]	PMC1168874_T224
PMC1168874	PMC1168874_191	[26157]	[26427]	['The use of non-teratogenic drugs may prevent the teratogenic effect of maternal diseases such as diabetes mellitus, influenza, and other acute infectious diseases with high fever and this preventable part of CAs exceeds the proportion of CAs caused by teratogenic drugs.']	drugs	CHEBI_EXT	[26421]	[26426]	PMC1168874_T225
PMC1168874	PMC1168874_192	[26428]	[26642]	['The periconceptional folic acid-containing multivitamin supplementation can prevent the major proportion of neural-tube defects and a considerable portion of cardiovascular, urinary tract CAs and limb deficiencies.']	folic acid	CHEBI_EXT	[26449]	[26459]	PMC1168874_T226
PMC1168874	PMC1168874_192	[26428]	[26642]	['The periconceptional folic acid-containing multivitamin supplementation can prevent the major proportion of neural-tube defects and a considerable portion of cardiovascular, urinary tract CAs and limb deficiencies.']	neural-tube	UBERON_EXT	[26536]	[26547]	PMC1168874_T535
PMC1168874	PMC1168874_192	[26428]	[26642]	['The periconceptional folic acid-containing multivitamin supplementation can prevent the major proportion of neural-tube defects and a considerable portion of cardiovascular, urinary tract CAs and limb deficiencies.']	cardiovascular	UBERON_EXT	[26586]	[26600]	PMC1168874_T536
PMC1168874	PMC1168874_192	[26428]	[26642]	['The periconceptional folic acid-containing multivitamin supplementation can prevent the major proportion of neural-tube defects and a considerable portion of cardiovascular, urinary tract CAs and limb deficiencies.']	urinary tract	UBERON_EXT	[26602]	[26615]	PMC1168874_T537
PMC1168874	PMC1168874_192	[26428]	[26642]	['The periconceptional folic acid-containing multivitamin supplementation can prevent the major proportion of neural-tube defects and a considerable portion of cardiovascular, urinary tract CAs and limb deficiencies.']	limb	UBERON_EXT	[26624]	[26628]	PMC1168874_T538
PMC1168874	PMC1168874_194	[26783]	[26930]	['Folic acid alone will also significantly reduce the first occurrence and recurrence of neural-tube defects.52\n\n© Ivyspring International Publisher.']	Folic acid	CHEBI_EXT	[26783]	[26793]	PMC1168874_T227
PMC1168874	PMC1168874_194	[26783]	[26930]	['Folic acid alone will also significantly reduce the first occurrence and recurrence of neural-tube defects.52\n\n© Ivyspring International Publisher.']	neural-tube	UBERON_EXT	[26870]	[26881]	PMC1168874_T539
